Document_and_Entity_Informatio
Document and Entity Information | 6 Months Ended | |
Mar. 31, 2014 | Apr. 30, 2014 | |
Document and Entity Information [Abstract] | ' | ' |
Trading Symbol | 'BRKS | ' |
Entity Registrant Name | 'BROOKS AUTOMATION INC | ' |
Entity Central Index Key | '0000933974 | ' |
Current Fiscal Year End Date | '--09-30 | ' |
Entity Filer Category | 'Large Accelerated Filer | ' |
Document Type | '10-Q | ' |
Document Period End Date | 31-Mar-14 | ' |
Document Fiscal Year Focus | '2014 | ' |
Document Fiscal Period Focus | 'Q2 | ' |
Amendment Flag | 'false | ' |
Entity Common Stock, Shares Outstanding | ' | 66,806,263 |
CONSOLIDATED_BALANCE_SHEETS
CONSOLIDATED BALANCE SHEETS (USD $) | Mar. 31, 2014 | Sep. 30, 2013 |
In Thousands, unless otherwise specified | ||
Current assets | ' | ' |
Cash and cash equivalents | $85,281 | $82,971 |
Restricted cash | 0 | 177 |
Marketable securities | 50,274 | 45,900 |
Accounts receivable, net | 83,440 | 77,483 |
Inventories | 93,750 | 94,411 |
Deferred tax assets | 16,082 | 16,839 |
Assets held for sale | 28,023 | 27,778 |
Prepaid expenses and other current assets | 12,489 | 9,030 |
Total current assets | 369,339 | 354,589 |
Property, plant and equipment, net | 52,759 | 47,506 |
Long-term marketable securities | 56,668 | 44,491 |
Long-term deferred tax assets | 97,422 | 99,146 |
Goodwill | 97,863 | 97,924 |
Intangible assets, net | 55,124 | 60,088 |
Equity investment in joint ventures | 30,342 | 25,687 |
Other assets | 7,704 | 7,332 |
Total assets | 767,221 | 736,763 |
Current liabilities | ' | ' |
Accounts payable | 35,672 | 35,392 |
Less current portion of capital lease obligation | 881 | 0 |
Deferred revenue | 33,116 | 19,610 |
Accrued warranty and retrofit costs | 6,319 | 7,260 |
Accrued compensation and benefits | 16,992 | 14,225 |
Accrued restructuring costs | 1,552 | 1,412 |
Accrued income taxes payable | 1,246 | 1,077 |
Liabilities held for sale | 107 | 132 |
Accrued expenses and other current liabilities | 16,979 | 13,453 |
Total current liabilities | 112,864 | 92,561 |
Long-term capital lease obligation | 7,656 | 0 |
Income taxes payable | 7,673 | 7,036 |
Long-term pension liability | 837 | 815 |
Other long-term liabilities | 3,790 | 3,695 |
Total liabilities | 132,820 | 104,107 |
Contingencies (Note 16) | ' | ' |
Equity | ' | ' |
Preferred stock, $0.01 par value, 1,000,000 shares authorized, no shares issued or outstanding | ' | ' |
Common stock, $0.01 par value, 125,000,000 shares authorized, 80,268,132 shares issued and 66,806,263 shares outstanding at March 31, 2014, 80,039,104 shares issued and 66,577,235 shares outstanding at September 30, 2013 | 803 | 800 |
Additional paid-in capital | 1,831,802 | 1,825,499 |
Accumulated other comprehensive income | 21,873 | 22,604 |
Treasury stock at cost, 13,461,869 shares | -200,956 | -200,956 |
Accumulated deficit | -1,019,945 | -1,015,991 |
Total Brooks Automation, Inc. stockholders' equity | 633,577 | 631,956 |
Noncontrolling interest in subsidiaries | 824 | 700 |
Total equity | 634,401 | 632,656 |
Total liabilities and equity | $767,221 | $736,763 |
CONSOLIDATED_BALANCE_SHEETS_Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) | Mar. 31, 2014 | Sep. 30, 2013 |
Statement of Financial Position [Abstract] | ' | ' |
Preferred stock, par value (USD per share) | $0.01 | $0.01 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value (USD per share) | $0.01 | $0.01 |
Common stock, shares authorized | 125,000,000 | 125,000,000 |
Common stock, shares issued | 80,268,132 | 80,039,104 |
Common stock, shares outstanding | 66,806,263 | 66,577,235 |
Treasury stock, shares | 13,461,869 | 13,461,869 |
CONSOLIDATED_STATEMENTS_OF_OPE
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 |
Revenues | ' | ' | ' | ' |
Product | $102,534 | $88,652 | $195,664 | $159,680 |
Services | 23,366 | 20,830 | 47,308 | 41,308 |
Total revenues | 125,900 | 109,482 | 242,972 | 200,988 |
Cost of revenues | ' | ' | ' | ' |
Product | 64,786 | 60,685 | 125,522 | 111,645 |
Services | 16,816 | 15,714 | 32,261 | 29,979 |
Total cost of revenues | 81,602 | 76,399 | 157,783 | 141,624 |
Gross profit | 44,298 | 33,083 | 85,189 | 59,364 |
Operating expenses | ' | ' | ' | ' |
Research and development | 12,493 | 11,333 | 25,044 | 22,237 |
Selling, general and administrative | 28,637 | 24,169 | 54,772 | 49,324 |
Restructuring and other charges | 772 | 751 | 1,519 | 5,441 |
Total operating expenses | 41,902 | 36,253 | 81,335 | 77,002 |
Operating income (loss) | 2,396 | -3,170 | 3,854 | -17,638 |
Interest income | 258 | 265 | 504 | 540 |
Interest expense | 0 | 0 | 0 | -1 |
Other income (expense), net | 56 | 77 | 315 | -16 |
Income (loss) before income taxes and equity in earnings (losses) of equity method investments | 2,710 | -2,828 | 4,673 | -17,115 |
Income tax benefit | 1,117 | 327 | 1,910 | -3,559 |
Income (loss) before equity in earnings (losses) of joint ventures | 1,593 | -3,155 | 2,763 | -13,556 |
Equity in earnings (losses) of joint ventures | 510 | -10 | 1,259 | -16 |
Income (loss) from continuing operations | 2,103 | -3,165 | 4,022 | -13,572 |
Income from discontinued operations, net of tax | 1,162 | 2,654 | 2,739 | 3,842 |
Net income (loss) | 3,265 | -511 | 6,761 | -9,730 |
Net income attributable to noncontrolling interests | -76 | -27 | -124 | -44 |
Net income (loss) attributable to Brooks Automation, Inc. | $3,189 | ($538) | $6,637 | ($9,774) |
Basic net income (loss) per share attributable to Brooks Automation, Inc. common stockholders: | ' | ' | ' | ' |
Net income (loss) from continuing operations (USD per share) | $0.03 | ($0.05) | $0.06 | ($0.21) |
Net income from discontinued operations, net of tax (USD per share) | $0.02 | $0.04 | $0.04 | $0.06 |
Basic net income (loss) per share attributable to Brooks Automation, Inc. (USD per share) | $0.05 | ($0.01) | $0.10 | ($0.15) |
Diluted net income (loss) per share attributable to Brooks Automation, Inc. common stockholders: | ' | ' | ' | ' |
Net income (loss) from continuing operations (USD per share) | $0.03 | ($0.05) | $0.06 | ($0.21) |
Net income from discontinued operations, net of tax (USD per share) | $0.02 | $0.04 | $0.04 | $0.06 |
Diluted net income (loss) per share attributable to Brooks Automation, Inc. common stockholders (USD per share) | $0.05 | ($0.01) | $0.10 | ($0.15) |
Dividend declared per share (USD per share) | $0.08 | $0.08 | $0.16 | $0.16 |
Shares used in computing earnings (loss) per share | ' | ' | ' | ' |
Basic (shares) | 66,646 | 65,889 | 66,499 | 65,726 |
Diluted (shares) | 67,505 | 65,889 | 67,383 | 65,726 |
CONSOLIDATED_STATEMENTS_OF_COM
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 |
Statement of Stockholders' Equity [Abstract] | ' | ' | ' | ' |
Net income (loss) | $3,265 | ($511) | $6,761 | ($9,730) |
Change in cumulative translation adjustment | -547 | -6,908 | -841 | -6,378 |
Change in unrealized gain (loss) on marketable securities | 22 | -23 | 21 | -152 |
Change in unrealized gain (loss) on cash flow hedges | -37 | 0 | 68 | 0 |
Actuarial gain (loss) | 10 | 23 | 21 | 313 |
Pension settlement | 0 | 0 | 0 | 87 |
Comprehensive loss | 2,713 | -7,419 | 6,030 | -15,860 |
Comprehensive income attributable to noncontrolling interests | -76 | -27 | -124 | -44 |
Comprehensive loss attributable to Brooks Automation, Inc. | $2,637 | ($7,446) | $5,906 | ($15,904) |
CONSOLIDATED_STATEMENTS_OF_CAS
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | 6 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 |
Cash flows from operating activities | ' | ' |
Net income (loss) | $6,761 | ($9,730) |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ' | ' |
Depreciation and amortization | 11,170 | 12,443 |
Impairment of assets | 398 | 0 |
Stock-based compensation | 6,516 | 5,010 |
Amortization of premium on marketable securities | 610 | 661 |
Undistributed (earnings) losses of equity method investments | -1,259 | 16 |
Deferred income tax benefit | 2,269 | -3,387 |
Pension settlement | 0 | 87 |
Loss on disposal of long-lived assets | 39 | -150 |
Changes in operating assets and liabilities, net of acquisitions and disposals: | ' | ' |
Accounts receivable | -6,057 | 9,489 |
Inventories | 276 | 13,734 |
Prepaid expenses and other current assets | 1,546 | -4,305 |
Accounts payable | 248 | -3,260 |
Deferred revenue | 13,408 | 3,711 |
Accrued warranty and retrofit costs | -951 | -1,154 |
Accrued compensation and benefits | 2,730 | -2,702 |
Accrued restructuring costs | 141 | 195 |
Accrued expenses and other current liabilities | -2,194 | -3,914 |
Net cash provided by operating activities | 35,651 | 16,744 |
Cash flows from investing activities | ' | ' |
Purchases of property, plant and equipment | -2,696 | -1,578 |
Purchases of marketable securities | -63,561 | -39,269 |
Sale/maturity of marketable securities | 46,551 | 98,178 |
Other investment | -4,000 | 0 |
Acquisition, net of cash acquired | 0 | -59,005 |
Proceeds from the sale of property, plant and equipment | 0 | 2,368 |
Payment of deferred leasing cost | 0 | -2,076 |
Decrease in restricted cash | 177 | 763 |
Net cash provided by (used in) investing activities | -23,529 | -619 |
Cash flows from financing activities | ' | ' |
Proceeds from issuance of common stock, net of issuance costs | 967 | 969 |
Common stock dividend paid | -10,800 | -10,672 |
Net cash used in financing activities | -9,833 | -9,703 |
Effects of exchange rate changes on cash and cash equivalents | 21 | -940 |
Net increase (decrease) in cash and cash equivalents | 2,310 | 5,482 |
Cash and cash equivalents, beginning of period | 82,971 | 54,639 |
Cash and cash equivalents, end of period | 85,281 | 60,121 |
Supplemental disclosure of non-cash investing and financing activities: | ' | ' |
Acquisition of buildings and land through capital lease | $8,537 | $0 |
Basis_of_Presentation
Basis of Presentation | 6 Months Ended |
Mar. 31, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Basis of Presentation | ' |
Basis of Presentation | |
The unaudited consolidated financial statements of Brooks Automation, Inc. and its subsidiaries (“Brooks” or the “Company”) included herein have been prepared in accordance with accounting principles generally accepted in the United States, or GAAP. All intercompany accounts and transactions have been eliminated. In the opinion of management, all material adjustments, which are of a normal and recurring nature, necessary for a fair presentation of the financial position results of operations for the periods presented have been reflected. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full fiscal year. | |
In the second quarter of 2014, the Company determined that its Granville-Phillips Gas Analysis & Vacuum Measurement ("Granville-Phillips") business met the criteria to be reported as a discontinued operation. As a result, the Company’s historical financial statements have been revised to present the operating results of Granville-Phillips as a discontinued operation. The results of operations from the Granville-Phillips business are presented as “Income from discontinued operations, net of tax” in the Consolidated Statements of Operations. Assets and liabilities identifiable within the Granville-Phillips business are reported as "Assets held for sale" and "Liabilities held for sale," respectively, in the Consolidated Balance Sheets. The discussion in the notes to these consolidated statements, unless otherwise noted, relate solely to the Company's continuing operations (See Note 3). | |
Certain information and footnote disclosures normally included in the Company’s annual consolidated financial statements have been condensed or omitted and, accordingly, the accompanying financial information should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K, filed with the United States Securities and Exchange Commission (the “SEC”) for the fiscal year ended September 30, 2013 (the "2013 Annual Report on Form 10-K"). | |
Use of Estimates | |
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates are associated with accounts receivable, inventories, intangible assets, goodwill, deferred income taxes, warranty obligations, revenue recognized using the percentage of completion method and stock-based compensation expense on performance-based awards. The Company bases its estimates on historical experience and various other assumptions, including in certain circumstances future projections, that management believes to be reasonable under the circumstances. Although the Company regularly assesses these estimates, actual results could differ from those estimates. Changes in estimates are recorded in the period in which they become known. | |
Recently Enacted Accounting Pronouncements | |
In July 2013, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance for presentation of unrecognized tax benefits. The prior guidance related to unrecognized tax benefits did not explicitly address financial statement presentation of unrecognized tax benefits when a net operating loss carryforward, a similar tax loss or a tax credit carryforward exists. The amended guidance eliminates the existing diversity in practice in the presentation of unrecognized tax benefits in these instances. Under the amended guidance, an unrecognized tax benefit, or a portion of an unrecognized tax benefit, will be presented in the financial statements as a reduction of a deferred tax asset when an operating loss carryforward, a similar tax loss or a tax credit carryforward exists, with limited exceptions. This amended guidance is effective for fiscal years beginning on or after December 15, 2013. The Company does not expect that the adoption of this guidance will have a material impact on its financial position or results of operations. | |
In April 2014, the FASB issued an amendment to the accounting guidance for reporting discontinued operations. The amended guidance raises the threshold for disposals to qualify as a discontinued operation by requiring a component of an entity that is held for sale, or has been disposed of by sale, to represent a strategic shift that has or will have a major effect on operations and financial results. Under the amended guidance, a strategic shift could include the disposal of a major line of business, a major geographical area, a major equity method investment or other major parts of an entity. In addition, the new guidance allows companies to have significant continuing involvement and continuing cash flows with the discontinued operation. The amended guidance is effective for fiscal years beginning on or after December 15, 2014. Early adoption is permitted for disposals, or classifications as held for sale, that have not been previously reported in financial statements. The Company has not applied this amended guidance to the Granville-Phillips discontinued operation. |
StockBased_Compensation
Stock-Based Compensation | 6 Months Ended | |||||||||||||||
Mar. 31, 2014 | ||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||||||||||||
Stock-Based Compensation | ' | |||||||||||||||
Stock-Based Compensation | ||||||||||||||||
The Company may issue stock options and restricted stock which vest upon the satisfaction of a performance condition and/or a service condition. In addition, the Company issues shares to participating employees pursuant to an employee stock purchase plan. | ||||||||||||||||
The following table reflects stock-based compensation expense, excluding amounts related to discontinued operations, recorded during the three and six months ended March 31, 2014 and 2013 (in thousands): | ||||||||||||||||
Three months ended | Six months ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Restricted stock | $ | 3,683 | $ | 2,341 | $ | 6,293 | $ | 4,672 | ||||||||
Employee stock purchase plan | 112 | 117 | 225 | 244 | ||||||||||||
$ | 3,795 | $ | 2,458 | $ | 6,518 | $ | 4,916 | |||||||||
The fair value per share of restricted stock is equal to the quoted price of the Company’s common stock on the date of grant, net of estimated forfeitures. The expense related to these awards is being recorded ratably over the vesting period. In addition, for stock-based awards where vesting is dependent upon achieving certain operating performance goals, the Company estimates the likelihood of achieving the performance goals. | ||||||||||||||||
During the six months ended March 31, 2014, the Company granted 1,409,557 shares of restricted stock to members of senior management of which 601,432 shares vest over the service period. The vesting of the remaining 808,125 shares will vary based on the achievement of certain financial performance goals which will be measured at the end of fiscal year 2014, and a continuing required service period. Total compensation expense on both of these awards is a maximum of $19.2 million, net of cancellations. Changes to the projected attainment against performance targets during fiscal 2014 may result in an adjustment to the amount of cumulative compensation recorded as of the date the estimate is revised. Of the 1,409,557 shares of restricted stock that the Company granted, 8,500 shares were granted to Granville-Phillips employees. | ||||||||||||||||
During the six months ended March 31, 2013, the Company granted 1,224,000 shares of restricted stock to members of senior management of which 546,625 shares vest over a required service period. The vesting of the remaining 677,375 shares depended upon the achievement of certain financial performance goals which were measured at the end of fiscal year 2013, and a continuing required service period. Based on the Company’s results for fiscal 2013 relative to the financial performance goals established in the grant, 460,615 of the 677,375 shares were earned. These awards will vest over the remaining service period. Total compensation expense on the awards granted during the six months ended March 31, 2013 is a maximum of $7.3 million, net of cancellations. However, the final compensation expense related to these awards is dependent on the award holders completing the remaining service period. Of the 1,224,000 shares of restricted stock that the Company granted, 29,380 shares were granted to Granville-Phillips employees. | ||||||||||||||||
Stock Option Activity | ||||||||||||||||
The following table summarizes stock option activity for the six months ended March 31, 2014: | ||||||||||||||||
Number of | Weighted- | Weighted | Aggregate | |||||||||||||
Options | Average | Average | Intrinsic Value | |||||||||||||
Remaining | Exercise Price | (In Thousands) | ||||||||||||||
Contractual Term | ||||||||||||||||
Outstanding at September 30, 2013 | 15,540 | $ | 15.86 | |||||||||||||
Outstanding at March 31, 2014 | 15,540 | 0.3 years | $ | 15.86 | $ | — | ||||||||||
Vested at March 31, 2014 | 15,540 | 0.3 years | $ | 15.86 | $ | — | ||||||||||
Options exercisable at March 31, 2014 | 15,540 | 0.3 years | $ | 15.86 | $ | — | ||||||||||
Based on the Company’s closing stock price of $10.93 as of March 31, 2014, there was no intrinsic value to the option holders. | ||||||||||||||||
No stock options were granted during the three or six months ended March 31, 2014 or 2013. There were no stock option exercises in the three or six months ended March 31, 2014. The total intrinsic value of options exercised during the three and six months ended March 31, 2013 was $19,000. The total cash received from participants as a result of stock option exercises during the three and six months ended March 31, 2013 was $67,000. | ||||||||||||||||
As of March 31, 2014, there was no future compensation cost related to stock options as all outstanding stock options have vested. | ||||||||||||||||
Restricted Stock Activity | ||||||||||||||||
The following table summarizes restricted stock activity for the six months ended March 31, 2014: | ||||||||||||||||
Shares | Weighted | |||||||||||||||
Average | ||||||||||||||||
Grant-Date | ||||||||||||||||
Fair Value | ||||||||||||||||
Outstanding at September 30, 2013 | 2,915,413 | $ | 11.25 | |||||||||||||
Awards granted | 1,409,557 | 9.46 | ||||||||||||||
Awards vested | (522,023 | ) | 9.37 | |||||||||||||
Awards canceled | (767,962 | ) | 10.63 | |||||||||||||
Outstanding at March 31, 2014 | 3,034,985 | $ | 10.9 | |||||||||||||
The fair value of restricted stock awards vested during the three months ended March 31, 2014 and 2013 was $1.8 million and $3.1 million, respectively. The fair value of restricted stock awards vested during the six months ended March 31, 2014 and 2013 was $4.9 million and $6.0 million, respectively. | ||||||||||||||||
As of March 31, 2014, the unrecognized compensation cost related to restricted stock that is expected to vest is $15.7 million and will be recognized over an estimated weighted average service period of 1.8 years. | ||||||||||||||||
Employee Stock Purchase Plan | ||||||||||||||||
A total of 115,132 shares were purchased under the employee stock purchase plan during the three and six months ended March 31, 2014 for aggregate proceeds of $1.0 million. A total of 115,751 shares were purchased under the employee stock purchase plan during the three and six months ended March 31, 2013 for aggregate proceeds of $1.0 million. |
Acquisition
Acquisition | 6 Months Ended | |||
Mar. 31, 2014 | ||||
Business Combinations [Abstract] | ' | |||
Acquisition | ' | |||
Acquisitions | ||||
Acquisition of Matrical | ||||
On August 1, 2013, the Company acquired certain assets and assumed certain liabilities of Matrical, Inc.’s ("Matrical") life science businesses (collectively “the Acquired assets”) for cash consideration of approximately $9.3 million, net of cash acquired. The acquisition of the Acquired assets provides the Company with the opportunity to enhance its existing product offerings in biobanking and sample management. | ||||
The Company recorded the assets and liabilities associated with the purchase of the Acquired assets at their fair values as of the acquisition date. The amounts recorded were as follows (in thousands): | ||||
Accounts receivable | $ | 636 | ||
Inventory | 2,095 | |||
Prepaid and other current assets | 103 | |||
Property, plant and equipment | 534 | |||
Completed technology | 500 | |||
Customer relationships | 1,500 | |||
Goodwill | 7,076 | |||
Debt | (902 | ) | ||
Accounts payable | (294 | ) | ||
Deferred revenue | (351 | ) | ||
Customer deposits | (1,249 | ) | ||
Other current liabilities | (322 | ) | ||
Total purchase price, net of cash acquired | $ | 9,326 | ||
In performing the purchase price allocation, the Company considered, among other factors, analyses of historical financial performance, its intention for future use of the Acquired assets, and estimates of future cash flows from the Acquired assets. The purchase price was allocated based upon the fair value of the identified assets acquired and liabilities assumed as of the acquisition date from a market participant’s perspective. | ||||
The Company used the relief-from-royalty method to value the completed technology and the excess earnings method to value the customer relationships. Cash flows were discounted at a rate of 18%. The weighted-average amortization periods are 4.6 years for completed technologies and 7.0 years for customer relationships. The intangible assets acquired will be amortized using the straight-line method because it approximates the pattern in which the economic benefits are expected to be realized. | ||||
Goodwill represents the excess of the purchase price over the fair values of the net tangible and intangible assets acquired and is primarily the result of expected synergies from combining the Matrical products with the Company's other life science products. Goodwill arising from the acquisition of the Acquired assets is deductible for tax purposes. | ||||
The operating results of the Acquired assets have been included in the results of operations for the Brooks Life Science Systems segment from the date of acquisition. | ||||
The Company completed the final allocation of the purchase price related to the Acquired assets in the first quarter of fiscal year 2014. Prior to finalizing the purchase price allocation in the first quarter of fiscal 2014, the Company made an adjustment to reduce the fair value of deferred revenue acquired in the acquisition and goodwill by $61,000. | ||||
Acquisition of Crossing | ||||
On October 29, 2012, the Company acquired all the outstanding stock of Crossing Automation Inc. (“Crossing”), a U.S. based provider of automation solutions and services primarily to global semiconductor front-end markets. The Company paid, in cash, an aggregate merger consideration of $59.0 million net of cash acquired. The acquisition of Crossing provides the Company with the opportunity to enhance its existing capabilities with respect to manufacturing of atmospheric and vacuum automation solutions within the semiconductor front-end market. | ||||
The Company recorded the assets and liabilities associated with Crossing at their fair values as of the acquisition date. The amounts recorded were as follows (in thousands): | ||||
Accounts receivable | $ | 5,356 | ||
Inventory | 8,668 | |||
Prepaid expenses | 1,968 | |||
Property, plant and equipment | 2,270 | |||
Completed technology | 10,530 | |||
Customer relationships | 20,010 | |||
Goodwill | 26,453 | |||
Other long term assets | 885 | |||
Accounts payable | (3,024 | ) | ||
Accrued liabilities | (5,172 | ) | ||
Deferred revenue | (319 | ) | ||
Other current liabilities | (388 | ) | ||
Other long-term liabilities | (8,232 | ) | ||
Total purchase price, net of cash acquired | $ | 59,005 | ||
In performing the purchase price allocation, the Company considered, among other factors, its intention for future use of the acquired assets, analyses of historical financial performance, and estimates of future cash flows from Crossing’s products and services. The purchase price was allocated based upon the fair value of the identified assets acquired and liabilities assumed as of the acquisition date from a market participant’s perspective. | ||||
The Company used the relief-from-royalty method to value the completed technology and the excess earnings method to value the customer relationships. Cash flows were discounted at a rate of 15%. The weighted-average amortization periods are 7.7 years for completed technologies and 8.0 years for customer relationships. The intangible assets acquired will be amortized using methods that approximate the pattern in which the economic benefits are expected to be realized, including variable declining balance and straight-line methods. | ||||
Goodwill is primarily the result of expected synergies from combining the operations of Crossing with the Company. Goodwill arising from the acquisition of Crossing is not deductible for tax purposes. | ||||
The operating results of Crossing have been included in the results of operations for the Brooks Product Solutions and Brooks Global Services segments from the date of acquisition. | ||||
The Company completed the final allocation of the purchase price related to Crossing in the fourth quarter of fiscal year 2013. |
Discontinued_Operations
Discontinued Operations | 6 Months Ended | |||||||||||||||
Mar. 31, 2014 | ||||||||||||||||
Discontinued Operations and Disposal Groups [Abstract] | ' | |||||||||||||||
Discontinued Operations | ' | |||||||||||||||
Discontinued Operations | ||||||||||||||||
The Granville-Phillips business unit develops, manufactures, sells and services vacuum measurement and gas analysis instrumentation to semiconductor and non-semiconductor customers. On March 18, 2014, the Company announced an agreement to sell this business to MKS Instruments, Inc. for $87.0 million in cash. The sale is subject to regulatory approval and customary closing conditions. The Company expects to complete the sale in the quarter ending June 30, 2014. The Company determined that its Granville-Phillips business met the criteria to be reported as a discontinued operation. As a result, the Company’s historical financial statements have been revised to present the operating results of the Granville-Phillips business as a discontinued operation. Summarized results of the discontinued operation are as follows (in thousands): | ||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Revenue | $ | 7,453 | $ | 7,137 | $ | 14,968 | $ | 13,656 | ||||||||
Income from discontinued operations | $ | 1,825 | $ | 2,198 | $ | 4,309 | $ | 3,602 | ||||||||
Income tax provision (benefit) | 663 | (456 | ) | 1,570 | (240 | ) | ||||||||||
Income from discontinued operations, net of tax | $ | 1,162 | $ | 2,654 | $ | 2,739 | $ | 3,842 | ||||||||
Assets and liabilities identifiable within the Granville-Phillips business are reported as "Assets held for sale" and "Liabilities held for sale," respectively, in the Consolidated Balance Sheets. The major classes of assets and liabilities of the discontinued operation as are follows (in thousands): | ||||||||||||||||
March 31, | September 30, | |||||||||||||||
2014 | 2013 | |||||||||||||||
Inventory | $ | 3,602 | $ | 3,308 | ||||||||||||
Property, plant and equipment | 315 | 364 | ||||||||||||||
Goodwill | 24,106 | 24,106 | ||||||||||||||
Assets held for sale | $ | 28,023 | $ | 27,778 | ||||||||||||
Deferred revenue | $ | 21 | $ | 43 | ||||||||||||
Accrued warranty and retrofit costs | 86 | 89 | ||||||||||||||
Liabilities held for sale | $ | 107 | $ | 132 | ||||||||||||
Assets and liabilities held for sale are classified as current in the Consolidated Balance Sheets because the Company expects to complete the sale of the Granville-Phillips business in the third quarter of fiscal 2014. |
Goodwill_and_Intangible_Assets
Goodwill and Intangible Assets | 6 Months Ended | |||||||||||||||||||||||
Mar. 31, 2014 | ||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ' | |||||||||||||||||||||||
Goodwill and Intangible Assets | ' | |||||||||||||||||||||||
Goodwill and Intangible Assets | ||||||||||||||||||||||||
Goodwill represents the excess of net book value over the estimated fair value of net tangible and identifiable intangible assets of a reporting unit. The Company performs an annual impairment test of its goodwill on September 30 of each fiscal year unless interim indicators of impairment exist. The Company did not identify any indicators of goodwill impairment during the six month period ended March 31, 2014 that would warrant an interim test. | ||||||||||||||||||||||||
The components of the Company’s goodwill, excluding amounts related to the discontinued operations, by business segment at March 31, 2014 are as follows (in thousands): | ||||||||||||||||||||||||
Brooks | Brooks | Brooks | Other | Total | ||||||||||||||||||||
Product | Global | Life Science | ||||||||||||||||||||||
Solutions | Services | Systems | ||||||||||||||||||||||
Gross goodwill at September 30, 2013 | $ | 482,637 | $ | 156,792 | $ | 47,439 | $ | 26,014 | $ | 712,882 | ||||||||||||||
Less: aggregate impairment charges recorded | (437,706 | ) | (151,238 | ) | — | (26,014 | ) | (614,958 | ) | |||||||||||||||
Goodwill, less accumulated impairments at September 30, 2013 | 44,931 | 5,554 | 47,439 | — | 97,924 | |||||||||||||||||||
Adjustments during the six months ended March 31, 2014 | — | — | (61 | ) | — | (61 | ) | |||||||||||||||||
Goodwill, less accumulated impairments at March 31, 2014 | $ | 44,931 | $ | 5,554 | $ | 47,378 | $ | — | $ | 97,863 | ||||||||||||||
Components of the Company’s identifiable intangible assets, excluding amounts related to the discontinued operations, are as follows (in thousands): | ||||||||||||||||||||||||
31-Mar-14 | September 30, 2013 | |||||||||||||||||||||||
Cost | Accumulated | Net Book | Cost | Accumulated | Net Book | |||||||||||||||||||
Amortization | Value | Amortization | Value | |||||||||||||||||||||
Patents | $ | 7,808 | $ | 7,248 | $ | 560 | $ | 7,808 | $ | 7,196 | $ | 612 | ||||||||||||
Completed technology | 53,557 | 39,211 | 14,346 | 57,050 | 40,354 | 16,696 | ||||||||||||||||||
Trademarks and trade names | 3,496 | 3,496 | — | 3,564 | 3,554 | 10 | ||||||||||||||||||
Customer relationships | 67,134 | 26,916 | 40,218 | 66,687 | 23,917 | 42,770 | ||||||||||||||||||
$ | 131,995 | $ | 76,871 | $ | 55,124 | $ | 135,109 | $ | 75,021 | $ | 60,088 | |||||||||||||
The Company is required to test certain long-lived assets when indicators of impairment are present. The Company determined that impairment indicators were present for the long-lived assets related to its Celigo product line as of September 30, 2013. The long-lived assets in question were tested for recoverability in the fourth quarter of fiscal year 2013 by comparing the sum of the undiscounted cash flows directly attributable to the assets to their carrying values, which resulted in the conclusion that the carrying amounts of the assets were not recoverable. The fair values of the assets were then evaluated to determine the amount of the impairment, if any. The fair value of the assets was based primarily on market-based valuation techniques. As a result of this analysis, management determined that an impairment loss of $2.0 million had occurred as of September 30, 2013, and allocated the loss to the long-lived assets in the impaired asset group based on the carrying value of each asset, with no asset reduced below its respective fair value. | ||||||||||||||||||||||||
The Company revised its estimate of the fair value of these assets at December 31, 2013 and determined that an additional impairment loss of $0.4 million, representing the remaining carrying value of the long-lived assets, was required. The impairment charge was recorded as a component of cost of revenue in the Consolidated Statements of Operations during the first quarter of fiscal 2014. The Company completed the sale of the Celigo product line in the second quarter of fiscal 2014. The sale of the Celigo product line did not have a material impact on the Company's financial position or result of operations. |
Income_Taxes
Income Taxes | 6 Months Ended |
Mar. 31, 2014 | |
Income Tax Disclosure [Abstract] | ' |
Income Taxes | ' |
Income Taxes | |
The Company recorded an income tax provision of $1.1 million and $1.9 million for the three and six months ended March 31, 2014, respectively. This tax provision substantially consists of U.S. and foreign income taxes, as well as interest related to unrecognized tax benefits. | |
The Company recorded an income tax provision (benefit) of $0.3 million and $(3.6) million for the three and six months ended March 31, 2013, respectively. The tax provision for both periods includes $0.9 million of tax benefits recognized during the quarter ended March 31, 2013 resulting from the reinstatement of the U.S. federal research and development tax credit. The tax benefit for the six months ended March 31, 2013 is primarily driven by tax benefits generated on U.S. losses partially offset by a tax provision on income in foreign jurisdictions. | |
The tax provision for the three months ended March 31, 2013 was calculated based on a quarterly loss. This unusual relationship between tax expense and pre-tax income was driven by a change in the estimated annual effective tax rate during the quarter which reduced the estimate of year-to-date tax benefits on the losses incurred during the first six months of the year. | |
The Company evaluates the realizability of its deferred tax assets by jurisdiction and assesses the need for a valuation allowance on a quarterly basis. As of March 31, 2014, the Company has continued to maintain a valuation allowance in the U.S. against certain tax credits and state net operating losses due to the uncertainty of their realization based on long-term Company forecasts and the expiration dates on these attributes. The Company has also continued to maintain a valuation allowance in certain jurisdictions that have not generated historical cumulative profitability. | |
The Company is subject to U.S. federal income tax and various state, local and foreign income taxes in various jurisdictions. The amount of income taxes paid is subject to the Company's interpretation of applicable tax laws in the jurisdictions in which it files. In the normal course of business, the Company is subject to examination by taxing authorities throughout the world. The Company has income tax audits in progress in various jurisdictions in which it operates. In the Company's U.S. and foreign jurisdictions, the years that may be examined vary, with the earliest tax year being 2006. Based on the outcome of these examinations, or the expiration of statutes of limitations for specific jurisdictions, the related unrecognized tax benefits could change from those recorded in the Company's Consolidated Balance Sheets. It is reasonably possible that the unrecognized tax benefit will be reduced by an amount in the range between $1.7 million and $2.8 million during the next twelve months as the result of the expiration of statutes of limitations and the settlement of foreign income tax audits. |
Earnings_per_Share
Earnings per Share | 6 Months Ended | |||||||||||
Mar. 31, 2014 | ||||||||||||
Earnings Per Share [Abstract] | ' | |||||||||||
Earnings per Share | ' | |||||||||||
Earnings per Share | ||||||||||||
Below is a reconciliation of weighted average common shares outstanding for purposes of calculating basic and diluted earnings per share (in thousands): | ||||||||||||
Three months ended | Six months ended | |||||||||||
March 31, | March 31, | |||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||
Weighted average common shares outstanding used in computing basic earnings per share | 66,646 | 65,889 | 66,499 | 65,726 | ||||||||
Dilutive common stock options and restricted stock awards | 859 | — | 884 | — | ||||||||
Weighted average common shares outstanding for purposes of computing diluted earnings per share | 67,505 | 65,889 | 67,383 | 65,726 | ||||||||
Options to purchase approximately 16,000 and 34,000 shares of common stock and 0 and 3,179,000 shares of restricted stock were excluded from the computation of diluted earnings per share attributable to common stockholders for the three months ended March 31, 2014 and 2013, respectively, as their effect would be anti-dilutive. In addition, options to purchase approximately 16,000 and 65,000 shares of common stock and 0 and 3,008,000 shares of restricted stock were excluded from the computation of diluted earnings per share attributable to common stockholders for the six months ended March 31, 2014 and 2013, respectively, as their effect would be anti-dilutive. All outstanding stock options and unvested shares of restricted stock were excluded from the computation of diluted earnings per share for the three and six months ended March 31, 2013 as a result of the net loss for those periods. |
Segment_Information
Segment Information | 6 Months Ended | |||||||||||||||
Mar. 31, 2014 | ||||||||||||||||
Segment Reporting [Abstract] | ' | |||||||||||||||
Segment Information | ' | |||||||||||||||
Segment Information | ||||||||||||||||
The Company reports financial results in three segments: Brooks Product Solutions, Brooks Global Services and Brooks Life Science Systems. A description of segments is included in the 2013 Annual Report on Form 10-K. | ||||||||||||||||
The Company evaluates performance and allocates resources based on revenues, operating income (loss) and returns on invested assets. Operating income (loss) for each segment includes selling, general and administrative expenses directly attributable to the segment. Other unallocated corporate expenses, amortization of acquired intangible assets (excluding completed technology) and restructuring and other charges are excluded from the segments’ operating income (loss). The Company’s indirect overhead costs, which include various general and administrative expenses, are allocated among the segments based upon multiple cost drivers associated with the respective administrative function, including segment revenue, segment headcount, or an analysis of the segments that benefit from a specific administrative function. Segment assets exclude cash, cash equivalents, restricted cash, marketable securities, deferred tax assets, assets held for sale and investments in equity method investments. | ||||||||||||||||
Financial information for the Company’s business segments, excluding amounts related to the discontinued operations, is as follows (in thousands): | ||||||||||||||||
Brooks | Brooks | Brooks | Total | |||||||||||||
Product | Global | Life Science | ||||||||||||||
Solutions | Services | Systems | ||||||||||||||
Three months ended March 31, 2014 | ||||||||||||||||
Revenue | ||||||||||||||||
Product | $ | 89,897 | $ | 4,213 | $ | 8,424 | $ | 102,534 | ||||||||
Services | — | 19,178 | 4,188 | 23,366 | ||||||||||||
$ | 89,897 | $ | 23,391 | $ | 12,612 | $ | 125,900 | |||||||||
Gross profit | $ | 31,960 | $ | 7,676 | $ | 4,662 | $ | 44,298 | ||||||||
Segment operating income (loss) | $ | 6,127 | $ | 2,248 | $ | (3,565 | ) | $ | 4,810 | |||||||
Three months ended March 31, 2013 | ||||||||||||||||
Revenue | ||||||||||||||||
Product | $ | 78,563 | $ | 3,731 | $ | 6,358 | $ | 88,652 | ||||||||
Services | — | 18,073 | 2,757 | 20,830 | ||||||||||||
$ | 78,563 | $ | 21,804 | $ | 9,115 | $ | 109,482 | |||||||||
Gross profit | $ | 24,313 | $ | 6,359 | $ | 2,411 | $ | 33,083 | ||||||||
Segment operating income (loss) | $ | 1,464 | $ | 1,799 | $ | (3,875 | ) | $ | (612 | ) | ||||||
Six months ended March 31, 2014 | ||||||||||||||||
Revenue | ||||||||||||||||
Product | $ | 171,453 | $ | 7,652 | $ | 16,559 | $ | 195,664 | ||||||||
Services | — | 39,058 | 8,250 | 47,308 | ||||||||||||
$ | 171,453 | $ | 46,710 | $ | 24,809 | $ | 242,972 | |||||||||
Gross profit | $ | 60,461 | $ | 15,501 | $ | 9,227 | $ | 85,189 | ||||||||
Segment operating income (loss) | $ | 10,455 | $ | 5,091 | $ | (7,040 | ) | $ | 8,506 | |||||||
Six months ended March 31 2013 | ||||||||||||||||
Revenue | ||||||||||||||||
Product | $ | 134,990 | $ | 7,236 | $ | 17,454 | $ | 159,680 | ||||||||
Services | — | 35,509 | 5,799 | 41,308 | ||||||||||||
$ | 134,990 | $ | 42,745 | $ | 23,253 | $ | 200,988 | |||||||||
Gross profit | $ | 39,293 | $ | 11,366 | $ | 8,705 | $ | 59,364 | ||||||||
Segment operating income (loss) | $ | (6,447 | ) | $ | 2,287 | $ | (3,897 | ) | $ | (8,057 | ) | |||||
Assets | ||||||||||||||||
31-Mar-14 | $ | 231,324 | $ | 61,856 | $ | 107,933 | $ | 401,113 | ||||||||
September 30, 2013 | $ | 226,759 | $ | 59,762 | $ | 105,221 | $ | 391,742 | ||||||||
A reconciliation of the Company’s reportable segment operating income (loss) to the corresponding consolidated amounts for the three and six month periods ended March 31, 2014 and 2013 is as follows (in thousands): | ||||||||||||||||
Three months ended | Six months ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Segment operating income (loss) | $ | 4,810 | $ | (612 | ) | $ | 8,506 | $ | (8,057 | ) | ||||||
Amortization of acquired intangible assets | 1,460 | 1,413 | 2,916 | 2,856 | ||||||||||||
Restructuring and other charges | 772 | 751 | 1,519 | 5,441 | ||||||||||||
Other unallocated corporate expenses | 182 | 394 | 217 | 1,284 | ||||||||||||
Total operating income (loss) | $ | 2,396 | $ | (3,170 | ) | $ | 3,854 | $ | (17,638 | ) | ||||||
A reconciliation of the Company’s reportable segment assets to the corresponding consolidated amounts as of March 31, 2014 and September 30, 2013 is as follows (in thousands): | ||||||||||||||||
March 31, | September 30, | |||||||||||||||
2014 | 2013 | |||||||||||||||
Segment assets | $ | 401,113 | $ | 391,742 | ||||||||||||
Cash, cash equivalents, restricted cash and marketable securities | 192,223 | 173,539 | ||||||||||||||
Deferred tax assets | 113,504 | 115,985 | ||||||||||||||
Assets held for sale | 28,023 | 27,778 | ||||||||||||||
Equity method investments | 30,342 | 25,687 | ||||||||||||||
Other unallocated corporate net assets | 2,016 | 2,032 | ||||||||||||||
Total assets | $ | 767,221 | $ | 736,763 | ||||||||||||
Significant_Customers
Significant Customers | 6 Months Ended |
Mar. 31, 2014 | |
Risks and Uncertainties [Abstract] | ' |
Significant Customers | ' |
Significant Customers | |
The Company had one customer that accounted for more than 10% of its revenue, at 10% and 13%, in each of the three months ended March 31, 2014 and 2013, respectively. The Company had one customer that accounted for more than 10% of revenue, at 12% and 11%, in each of the six months ended March 31, 2014 and 2013, respectively. The Company did not have any customers that accounted for more than 10% of its accounts receivable balance at March 31, 2014 or September 30, 2013. |
Restructuring_and_Other_Charge
Restructuring and Other Charges | 6 Months Ended | |||||||||||||||
Mar. 31, 2014 | ||||||||||||||||
Restructuring and Related Activities [Abstract] | ' | |||||||||||||||
Restructuring and Other Charges | ' | |||||||||||||||
Restructuring and Other Charges | ||||||||||||||||
Restructuring charges in the three and six months ended March 31, 2014 consisted primarily of severance and other workforce-related costs and result from the consolidation of certain administrative functions in the Brooks Life Science Systems segment, the on-going transition of manufacturing certain of the Company’s Polycold products to a third party contract manufacturer and other programs designed to improve the Company’s cost structure. | ||||||||||||||||
Total severance charges related to the outsourcing of the Polycold manufacturing operation are expected to be $1.1 million, including severance and retention fees. This charge is being recorded ratably over the period from notification of the closing to the actual service end date, or September 2014. The Company has expensed $0.8 million of the total charge as of March 31, 2014, and will expense the balance ratably through fiscal year 2014. | ||||||||||||||||
Restructuring charges in the three and six months ended March 31, 2013 consisted of severance costs for workforce reductions implemented to consolidate the operations of Crossing and the Company, to transition the Polycold product line to a third party contract manufacturer and other programs designed to improve the Company’s cost structure. Restructuring charges also included costs to consolidate two of the Company's facilities in California. In addition, the Company incurred other charges of $0.1 million related to a partial settlement of a defined benefit pension plan that covers substantially all of the Company’s Swiss employees. | ||||||||||||||||
The activity for the three and six months ended March 31, 2014 and 2013 related to the Company's restructuring-related accruals, excluding amounts related to the discontinued operations, is summarized below (in thousands): | ||||||||||||||||
Activity — Three Months Ended March 31, 2014 | ||||||||||||||||
Balance at | Expense | Utilization | Balance at | |||||||||||||
December 31, | March 31, | |||||||||||||||
2013 | 2014 | |||||||||||||||
Facilities and other | $ | 57 | $ | 7 | $ | (64 | ) | $ | — | |||||||
Workforce-related | 1,405 | 765 | (618 | ) | 1,552 | |||||||||||
$ | 1,462 | $ | 772 | $ | (682 | ) | $ | 1,552 | ||||||||
Activity - Three Months Ended March 31, 2013 | ||||||||||||||||
Balance at | Expense | Utilization | Balance at | |||||||||||||
December 31, | March 31, | |||||||||||||||
2012 | 2013 | |||||||||||||||
Facilities and other | $ | 265 | $ | 112 | $ | (144 | ) | $ | 233 | |||||||
Workforce-related | 4,438 | 639 | (2,746 | ) | 2,331 | |||||||||||
$ | 4,703 | $ | 751 | $ | (2,890 | ) | $ | 2,564 | ||||||||
Activity — Six Months Ended March 31, 2014 | ||||||||||||||||
Balance at | Expense | Utilization | Balance at | |||||||||||||
September 30, | March 31, | |||||||||||||||
2013 | 2014 | |||||||||||||||
Facilities and other | $ | 155 | $ | 13 | $ | (168 | ) | $ | — | |||||||
Workforce-related | 1,257 | 1,506 | (1,211 | ) | 1,552 | |||||||||||
$ | 1,412 | $ | 1,519 | $ | (1,379 | ) | $ | 1,552 | ||||||||
Activity — Six Months Ended March 31, 2013 | ||||||||||||||||
Balance at | Expense | Utilization | Balance at | |||||||||||||
September 30, | March 31, | |||||||||||||||
2012 | 2013 | |||||||||||||||
Facilities and other | $ | — | $ | 690 | $ | (457 | ) | $ | 233 | |||||||
Workforce-related | 2,021 | 4,664 | (4,354 | ) | 2,331 | |||||||||||
$ | 2,021 | $ | 5,354 | $ | (4,811 | ) | $ | 2,564 | ||||||||
The Company anticipates that the accrued restructuring costs at March 31, 2014 will be paid in the next twelve months. |
Employee_Benefit_Plans
Employee Benefit Plans | 6 Months Ended | |||||||||||||||
Mar. 31, 2014 | ||||||||||||||||
Compensation and Retirement Disclosure [Abstract] | ' | |||||||||||||||
Employee Benefit Plans | ' | |||||||||||||||
Employee Benefit Plans | ||||||||||||||||
The Company has two active defined benefit pension plans (collectively, the “Plans”). The Plans cover substantially all of the Company’s employees in Switzerland and Taiwan. Retirement benefits are generally earned based on years of service and compensation during active employment; however, the level of benefits varies within the Plans. Eligibility is determined in accordance with local statutory requirements. | ||||||||||||||||
In connection with actions taken under the Company’s restructuring programs in the first quarter of fiscal 2013, the number of employees accumulating benefits under the Switzerland Plan declined significantly. As a result, a partial settlement event occurred and resulted in accelerated amortization of approximately $0.1 million of prior pension losses. The settlement loss, recorded in the quarter ended December 31, 2012, is included in restructuring and other charges in the Consolidated Statements of Operations. | ||||||||||||||||
The components of the Company’s net pension cost for the three and six months ended March 31, 2014 and 2013 is as follows (in thousands): | ||||||||||||||||
Three months ended | Six months ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Service cost | $ | 102 | $ | 144 | $ | 202 | $ | 322 | ||||||||
Interest cost | 39 | 35 | 78 | 80 | ||||||||||||
Amortization of losses | — | 1 | 1 | 3 | ||||||||||||
Expected return on assets | (55 | ) | (58 | ) | (108 | ) | (135 | ) | ||||||||
Net periodic pension cost | 86 | 122 | 173 | 270 | ||||||||||||
Settlement loss | — | — | — | 87 | ||||||||||||
Total pension cost | $ | 86 | $ | 122 | $ | 173 | $ | 357 | ||||||||
Capital_Lease_Obligation
Capital Lease Obligation | 6 Months Ended | |||
Mar. 31, 2014 | ||||
Leases [Abstract] | ' | |||
Capital Lease Obligation | ' | |||
Capital Lease Obligation | ||||
In March 2014, the Company exercised an option to renew the lease of a building and the related land on the Chelmsford, Massachusetts campus. The Company has leased this building since 2002. By exercising this option, the Company has also contracted to purchase the building at the end of the lease period. The assets acquired under the lease were recorded at the net present value of the minimum lease payments which was then allocated to the building and the land based on their relative fair values. The cost of the building and the land under the capital lease are included in the Consolidated Balance Sheets as property, plant and equipment at $6.4 million and $2.1 million, respectively. Depreciation expense related to the building is computed using the straight-line method over the estimated useful life of the asset. | ||||
The obligation related to the capital lease is recorded as short-term or long-term obligation in the Consolidated Balance Sheets depending on when payments are due. The future minimum lease payments required under the capital lease and the present value of the net minimum lease payments, as of March 31, 2014, are as follows (in thousands): | ||||
Year ended September 30, | ||||
2014 | $ | 441 | ||
2015 | 881 | |||
2016 | 881 | |||
2017 | 881 | |||
2018 | 6,901 | |||
Total minimum lease payments | 9,985 | |||
Less amounts representing interest | 1,448 | |||
Total capital lease obligation | 8,537 | |||
Less current portion of capital lease obligation | 881 | |||
Long-term capital lease obligation | $ | 7,656 | ||
Other_Balance_Sheet_Informatio
Other Balance Sheet Information | 6 Months Ended | ||||||||||||||||||
Mar. 31, 2014 | |||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' | ||||||||||||||||||
Other Balance Sheet Information | ' | ||||||||||||||||||
Other Balance Sheet Information | |||||||||||||||||||
The following is a summary of accounts receivable at March 31, 2014 and September 30, 2013 (in thousands): | |||||||||||||||||||
March 31, | September 30, | ||||||||||||||||||
2014 | 2013 | ||||||||||||||||||
Accounts receivable | $ | 84,770 | $ | 78,460 | |||||||||||||||
Less allowance for doubtful accounts | (1,184 | ) | (863 | ) | |||||||||||||||
Less allowance for sales returns | (146 | ) | (114 | ) | |||||||||||||||
$ | 83,440 | $ | 77,483 | ||||||||||||||||
The following is a summary of inventories at March 31, 2014 and September 30, 2013, excluding amounts related to the discontinued operations (in thousands): | |||||||||||||||||||
March 31, | September 30, | ||||||||||||||||||
2014 | 2013 | ||||||||||||||||||
Inventories | |||||||||||||||||||
Raw materials and purchased parts | $ | 59,844 | $ | 57,678 | |||||||||||||||
Work-in-process | 17,083 | 19,991 | |||||||||||||||||
Finished goods | 16,823 | 16,742 | |||||||||||||||||
$ | 93,750 | $ | 94,411 | ||||||||||||||||
Reserves for excess and obsolete inventory were $24.1 million, excluding amounts related to the discontinued operations, at March 31, 2014 and September 30, 2013. | |||||||||||||||||||
The Company provides for the estimated cost of product warranties, primarily from historical information, at the time product revenue is recognized and retrofit accruals at the time retrofit programs are established. The Company’s warranty obligation is affected by product failure rates, utilization levels, material usage, service delivery costs incurred in correcting a product failure, and supplier warranties on parts delivered to the Company. | |||||||||||||||||||
Product warranty and retrofit activity on a gross basis for the three and six months ended March 31, 2014 and 2013, excluding amounts related to the discontinued operations, is as follows (in thousands): | |||||||||||||||||||
Activity - Three Months Ended March 31, 2014 | |||||||||||||||||||
Balance at | Adjustments for | Accruals | Costs Incurred | Balance at | |||||||||||||||
December 31, | Acquisitions and Divestitures | March 31, | |||||||||||||||||
2013 | 2014 | ||||||||||||||||||
$ | 6,762 | $ | — | $ | 2,275 | $ | (2,718 | ) | $ | 6,319 | |||||||||
Activity - Three Months Ended March 31, 2013 | |||||||||||||||||||
Balance at | Adjustments for | Accruals | Costs Incurred | Balance at | |||||||||||||||
December 31, | Acquisitions and Divestitures | March 31, | |||||||||||||||||
2012 | 2013 | ||||||||||||||||||
$ | 7,637 | $ | — | $ | 2,985 | $ | (2,987 | ) | $ | 7,635 | |||||||||
Activity - Six Months Ended March 31, 2014 | |||||||||||||||||||
Balance at | Adjustments for | Accruals | Costs Incurred | Balance at | |||||||||||||||
September 30, | Acquisitions and Divestitures | March 31, | |||||||||||||||||
2013 | 2014 | ||||||||||||||||||
$ | 7,260 | $ | — | $ | 4,150 | $ | (5,091 | ) | $ | 6,319 | |||||||||
Activity - Six Months Ended March 31, 2013 | |||||||||||||||||||
Balance at | Adjustments for | Accruals | Costs Incurred | Balance at | |||||||||||||||
September 30, | Acquisitions and Divestitures | March 31, | |||||||||||||||||
2012 | 2013 | ||||||||||||||||||
$ | 7,246 | $ | 962 | $ | 5,317 | $ | (5,890 | ) | $ | 7,635 | |||||||||
Joint_Ventures
Joint Ventures | 6 Months Ended |
Mar. 31, 2014 | |
Equity Method Investments and Joint Ventures [Abstract] | ' |
Equity Method Investments | ' |
Equity Method Investments | |
The Company accounts for its equity method investments using the equity method. Under this method of accounting, the Company records in income its proportionate share of the earnings (losses) of the investee with a corresponding increase (decrease) in the carrying value of the investment. | |
BioCision, LLC | |
In March 2014, the Company acquired a 22% equity interest in BioCision, LLC (“BioCision”), a privately-held company based in Larkspur, California, for $4.0 million. BioCision develops, manufactures and markets cell cryopreservation products used to improve biomaterial sample handling and standardization. | |
ULVAC Cryogenics, Inc. | |
The Company participates in a 50% joint venture, ULVAC Cryogenics, Inc. (“UCI”), with ULVAC Corporation of Chigasaki, Japan. UCI manufactures and sells cryogenic vacuum pumps, principally to ULVAC Corporation. For the three months ended March 31, 2014 and 2013, the Company recorded income (expense) associated with UCI of $0.5 million and $(16,000), respectively. For the six months ended March 31, 2014 and 2013, the Company recorded income associated with UCI of $1.2 million and $62,000, respectively. At March 31, 2014, the carrying value of UCI in the Company’s Consolidated Balance Sheet was $23.4 million. For each of the three months ended March 31, 2014 and 2013, management fee payments received by the Company from UCI were $0.1 million. For the six months ended March 31, 2014 and 2013, management fee payments received by the Company from UCI were $0.3 million and $0.2 million, respectively. For the three months ended March 31, 2014 and 2013, the Company incurred charges from UCI for products or services of $37,000 and $0.1 million, respectively. For the six months ended March 31, 2014 and 2013, the Company incurred charges from UCI for products or services of $0.1 million and $0.4 million, respectively. At March 31, 2014 and September 30, 2013, the Company owed UCI $27,000 and $26,000, respectively, in connection with accounts payable for unpaid products and services. | |
Yaskawa Brooks Automation, Inc. | |
The Company participates in a 50% joint venture with Yaskawa Electric Corporation (“Yaskawa”) called Yaskawa Brooks Automation, Inc. (“YBA”) to exclusively market and sell Yaskawa’s semiconductor robotics products and Brooks’ automation hardware products to semiconductor customers in Japan. For the three months ended March 31, 2014 and 2013, the Company recorded income associated with YBA of $35,000 and $6,000, respectively. For the six months ended March 31, 2014 and 2013, the Company recorded income (expense) associated with YBA of $17,000 and $(78,000), respectively. At March 31, 2014, the carrying value of YBA in the Company’s Consolidated Balance Sheet was $2.9 million. For the three months ended March 31, 2014 and 2013, revenue earned by the Company from YBA was $2.1 million and $1.3 million, respectively. For the six months ended March 31, 2014 and 2013, revenue earned by the Company from YBA was $2.8 million and $2.9 million, respectively. For each of the three months ended March 31, 2014 and 2013, the Company incurred charges from YBA for products or services of $0.2 million. For each of the six months ended March 31, 2014 and 2013, the Company incurred charges from YBA for products or services of $0.3 million. | |
The amount due from YBA included in accounts receivable at March 31, 2014 and September 30, 2013 was $2.1 million and $2.3 million, respectively. At March 31, 2014 and September 30, 2013 the Company owed YBA $0 and $47,000 in connection with accounts payable for unpaid products and services. |
Derivative_Instruments
Derivative Instruments | 6 Months Ended | ||||||||||||||||||||
Mar. 31, 2014 | |||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ' | ||||||||||||||||||||
Derivative Instruments | ' | ||||||||||||||||||||
Derivative Instruments | |||||||||||||||||||||
All derivatives, whether designated in a hedging relationship or not, are recorded on the Consolidated Balance Sheets at fair value. The accounting for changes in fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based on the exposure being hedged, as a fair value hedge, cash flow hedge or a hedge of a net investment in a foreign operation. | |||||||||||||||||||||
A cash flow hedge is a derivative instrument designated for the purpose of hedging the exposure to variability in future cash flows resulting from a particular risk. If the derivative is designated as a cash flow hedge, the effective portions of changes in the fair value of the derivative are recorded in accumulated other comprehensive income and are recognized in the results of operations when the hedged item affects earnings. Ineffective portions of changes in the fair value of cash flow hedges are recognized in the results of operations. | |||||||||||||||||||||
In June 2013, the Company entered into foreign exchange contracts to reduce its exposure to changes in foreign exchange rates associated with an order for multiple automated sample management systems. The Company concluded that these foreign currency contracts meet the criteria to qualify as a cash flow hedge. Accordingly, the Company is reflecting changes in the fair value of the effective portion of these foreign currency contracts in accumulated other comprehensive income. Amounts recorded in accumulated other comprehensive income will be reclassified to revenue in the Consolidated Statements of Operations when the forecasted transaction occurs. | |||||||||||||||||||||
The Company had the following notional amounts outstanding under foreign currency contracts that qualify for cash flow hedge accounting at March 31, 2014 (in thousands): | |||||||||||||||||||||
Buy Currency | Notional Amount | Sell Currency | Maturity | Notional Amount | Fair Value of | Fair Value of | |||||||||||||||
of Buy Currency in U.S. Dollars | of Sell Currency | Assets | Liabilities | ||||||||||||||||||
in U.S. Dollars | |||||||||||||||||||||
U.S. Dollar | $ | 2,037 | Japanese Yen | Apr-14 | $ | 1,946 | $ | 91 | $ | — | |||||||||||
The Company expects to classify the accumulated gain on these contracts into revenue in the third quarter of fiscal 2014. The Company did not recognize any amounts related to ineffectiveness in the results of operations for the six months ended March 31, 2014. | |||||||||||||||||||||
In addition, the Company has various transactions and balances denominated in currencies other than the U.S. dollar. Most of these transactions or balances are denominated in Euros, British Pounds and a variety of Asian currencies. These transactions and balances, including short-term advances between the Company and its subsidiaries, subject the Company's operations to exposure from exchange rate fluctuations. The impact of currency exchange rate movement can be positive or negative in any period. The Company mitigates the impact of potential currency translation gains and losses on short-term intercompany advances through timely settlement of each transaction, generally within 30 days. | |||||||||||||||||||||
The Company also enters into foreign exchange contracts to reduce its exposure to currency translation. Under forward contract arrangements, the Company typically agrees to purchase a fixed amount of U.S. Dollars in exchange for a fixed amount of a foreign currency on specified dates with maturities of three months or less. These transactions do not qualify for hedge accounting. For derivative instruments not designated as hedging instruments, changes in fair value are recognized in the Consolidated Statements of Operations as gains and losses consistent with the classification of the underlying risk. | |||||||||||||||||||||
Net gains and losses recorded as a component of Other Income (Expense), net in the Consolidated Statements of Operations related to these contracts for the three and six month periods ended March 31, 2014 and 2013 is as follows (in thousands): | |||||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||||
March 31, | March 31, | ||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||||||
Realized gains (losses) on derivative instruments not designated as hedging instruments | $ | (0.2 | ) | $ | 0.1 | $ | (0.1 | ) | $ | 0.1 | |||||||||||
The Company had the following notional amounts outstanding under foreign currency contracts that do not qualify for hedge accounting at March 31, 2014 and September 30, 2013 (in thousands): | |||||||||||||||||||||
March 31, 2014: | |||||||||||||||||||||
Buy Currency | Notional Amount | Sell Currency | Maturity | Notional Amount | Fair Value of | Fair Value of | |||||||||||||||
of Buy Currency | of Sell Currency | Assets | Liabilities | ||||||||||||||||||
in U.S. Dollars | |||||||||||||||||||||
U.S. Dollar | $ | 2,976 | Japanese Yen | April to June 2014 | $ | 2,973 | $ | 3 | $ | — | |||||||||||
British Pound | 2,470 | Euro | April 2014 | 2,488 | — | (18 | ) | ||||||||||||||
U.S. Dollar | 698 | Taiwan Dollar | April 2014 | 697 | 1 | — | |||||||||||||||
Korean Won | 605 | U.S. Dollar | April 2014 | 602 | 3 | — | |||||||||||||||
U.S. Dollar | 428 | Israeli Shekel | April 2014 | 431 | — | (3 | ) | ||||||||||||||
$ | 7,177 | $ | 7,191 | $ | 7 | $ | (21 | ) | |||||||||||||
September 30, 2013: | |||||||||||||||||||||
Buy Currency | Notional Amount | Sell Currency | Maturity | Notional Amount | Fair Value of | Fair Value of | |||||||||||||||
of Buy Currency in U.S. Dollars | of Sell Currency | Assets | Liabilities | ||||||||||||||||||
in U.S. Dollars | |||||||||||||||||||||
U.S. Dollar | $ | 2,770 | Japanese Yen | October 2013 to December 2013 | $ | 2,762 | $ | 8 | $ | — | |||||||||||
Korean Won | 686 | U.S. Dollar | October 2013 | 688 | — | 2 | |||||||||||||||
U.S. Dollar | 301 | Israeli Shekel | October 2013 | 304 | — | 3 | |||||||||||||||
U.S. Dollar | 231 | Singapore Dollar | October 2013 | 231 | — | — | |||||||||||||||
$ | 3,988 | $ | 3,985 | $ | 8 | $ | 5 | ||||||||||||||
The fair values of the forward contracts described above are recorded in the Company's Consolidated Balance Sheets as Prepaid Expenses and Other Current Assets and Accrued Expenses and Other Current Liabilities. |
Marketable_Securities
Marketable Securities | 6 Months Ended | |||||||||||||||
Mar. 31, 2014 | ||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | ' | |||||||||||||||
Marketable Securities | ' | |||||||||||||||
Marketable Securities | ||||||||||||||||
The Company invests its cash in marketable securities and classifies them as available-for-sale. The Company records these securities at fair value. Marketable securities reported as current assets represent investments that mature within one year from the balance sheet date. Long-term marketable securities represent investments with maturity dates greater than one year from the balance sheet date. At the time that the maturity dates of these investments become one year or less, the securities are reclassified to current assets. Unrealized gains and losses are excluded from earnings and reported in a separate component of stockholders’ equity until they are sold or mature. At the time of sale, any gains or losses, calculated by the specific identification method, will be recognized as a component of operating results. | ||||||||||||||||
The following is a summary of marketable securities (included in short and long-term marketable securities in the Consolidated Balance Sheets), including accrued interest receivable, as of March 31, 2014 and September 30, 2013 (in thousands): | ||||||||||||||||
Amortized | Gross | Gross | Fair Value | |||||||||||||
Cost | Unrealized | Unrealized | ||||||||||||||
Gains | Losses | |||||||||||||||
March 31, 2014: | ||||||||||||||||
U.S. Treasury securities and obligations of U.S. government agencies | $ | 15,876 | $ | 3 | $ | (35 | ) | $ | 15,844 | |||||||
Corporate securities | 53,419 | 36 | (30 | ) | 53,425 | |||||||||||
Mortgage-backed securities | 1,035 | 31 | — | 1,066 | ||||||||||||
Other debt securities | 899 | — | — | 899 | ||||||||||||
Municipal securities | 23,882 | 11 | (9 | ) | 23,884 | |||||||||||
Bank certificate of deposits | 11,823 | 1 | — | 11,824 | ||||||||||||
$ | 106,934 | $ | 82 | $ | (74 | ) | $ | 106,942 | ||||||||
September 30, 2013: | ||||||||||||||||
U.S. Treasury securities and obligations of U.S. government agencies | $ | 19,528 | $ | 6 | $ | (13 | ) | $ | 19,521 | |||||||
Corporate securities | 35,045 | 11 | (47 | ) | 35,009 | |||||||||||
Mortgage-backed securities | 1,093 | 25 | (1 | ) | 1,117 | |||||||||||
Other debt securities | 88 | — | — | 88 | ||||||||||||
Municipal securities | 25,199 | 15 | (7 | ) | 25,207 | |||||||||||
Bank certificate of deposits | 9,451 | — | (2 | ) | 9,449 | |||||||||||
$ | 90,404 | $ | 57 | $ | (70 | ) | $ | 90,391 | ||||||||
The fair value of the marketable securities at March 31, 2014 by contractual maturity, are shown below (in thousands). Expected maturities could differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties. | ||||||||||||||||
Fair Value | ||||||||||||||||
Due in one year or less | $ | 50,274 | ||||||||||||||
Due after one year through five years | 53,291 | |||||||||||||||
Due after ten years | 3,377 | |||||||||||||||
$ | 106,942 | |||||||||||||||
Fair_Value_Measurements
Fair Value Measurements | 6 Months Ended | ||||||||||||||||
Mar. 31, 2014 | |||||||||||||||||
Fair Value Disclosures [Abstract] | ' | ||||||||||||||||
Fair Value Measurements | ' | ||||||||||||||||
Fair Value Measurements | |||||||||||||||||
The fair value measurement guidance establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: | |||||||||||||||||
Level 1: Quoted prices in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset and liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. | |||||||||||||||||
Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. | |||||||||||||||||
Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. | |||||||||||||||||
Assets and liabilities of the Company measured at fair value on a recurring basis as of March 31, 2014 and September 30, 2013 are summarized as follows (in thousands): | |||||||||||||||||
Fair Value Measurements at Reporting Date Using | |||||||||||||||||
Description | March 31, | Quoted Prices in | Significant Other | Significant | |||||||||||||
2014 | Active Markets for | Observable Inputs | Unobservable Inputs | ||||||||||||||
Identical Assets | (Level 2) | (Level 3) | |||||||||||||||
(Level 1) | |||||||||||||||||
Assets | |||||||||||||||||
Cash equivalents | $ | 6,532 | $ | 16 | $ | 6,516 | $ | — | |||||||||
Available-for-sale securities | 106,942 | — | 106,942 | — | |||||||||||||
Foreign exchange contracts | 98 | — | 98 | — | |||||||||||||
Total Assets | $ | 113,572 | $ | 16 | $ | 113,556 | $ | — | |||||||||
Liabilities | |||||||||||||||||
Foreign exchange contracts | $ | 21 | $ | — | $ | 21 | $ | — | |||||||||
Fair Value Measurements at Reporting Date Using | |||||||||||||||||
Description | September 30, | Quoted Prices in | Significant Other | Significant | |||||||||||||
2013 | Active Markets for | Observable Inputs | Unobservable Inputs | ||||||||||||||
Identical Assets | (Level 2) | (Level 3) | |||||||||||||||
(Level 1) | |||||||||||||||||
Assets | |||||||||||||||||
Cash equivalents | $ | 7,754 | $ | 6,152 | $ | 1,602 | $ | — | |||||||||
Available-for-sale securities | 90,391 | 2,199 | 88,192 | — | |||||||||||||
Foreign exchange contracts | 31 | — | 31 | — | |||||||||||||
Total Assets | $ | 98,176 | $ | 8,351 | $ | 89,825 | $ | — | |||||||||
Liabilities | |||||||||||||||||
Foreign exchange contracts | $ | 5 | $ | — | $ | 5 | $ | — | |||||||||
Cash Equivalents | |||||||||||||||||
Cash equivalents of $16,000 and $6.2 million at March 31, 2014 and September 30, 2013, respectively, consisting of Money Market Funds, are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices in active markets. Cash equivalents of $6.5 million and $1.6 million at March 31, 2014 and September 30, 2013, respectively, consisting of Bank Certificate of Deposits, U.S. Government Agency Securities and Municipal Securities, are classified within Level 2 of the hierarchy because they are not actively traded. | |||||||||||||||||
Available-For-Sale Securities | |||||||||||||||||
Available-for-sale securities of $2.2 million at September 30, 2013, consisting primarily of highly rated Corporate Bonds, are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices in active markets of identical assets or liabilities. Available-for-sale securities of $106.9 million and $88.2 million at March 31, 2014 and September 30, 2013, respectively, consisting of Municipal Securities, Bank Certificate of Deposits, Commercial Paper, U.S. Treasury Securities and Obligations of U.S. Government Agency Securities, and Mortgage-Backed Securities are classified within Level 2 of the fair value hierarchy because they are not actively traded and are valued using matrix pricing and benchmarking. Matrix pricing is a mathematical technique used to value securities by relying on the securities’ relationship to other benchmark quoted prices. | |||||||||||||||||
Foreign Exchange Contracts | |||||||||||||||||
Foreign exchange contract assets and liabilities are classified within Level 2 of the fair value hierarchy because there may not be an active market for each contract. However, the inputs used to calculate the value of the contract were obtained from an active market. |
Contingencies
Contingencies | 6 Months Ended |
Mar. 31, 2014 | |
Commitments and Contingencies Disclosure [Abstract] | ' |
Commitments and Contingencies | ' |
Commitments and Contingencies | |
Letters of Credit | |
At March 31, 2014, the Company had approximately $20.5 million of letters of credit outstanding that it issued. | |
Contingencies | |
The Company is subject to various legal proceedings, both asserted and unasserted, that arise in the ordinary course of business. The Company cannot predict the ultimate outcome of such legal proceedings or in certain instances provide reasonable ranges of potential losses. However, as of the date of this report, the Company believes that none of these claims will have a material adverse effect on its consolidated financial condition or results of operations. In the event of unexpected subsequent developments and given the inherent unpredictability of these legal proceedings, there can be no assurance that the Company's assessment of any claim will reflect the ultimate outcome and an adverse outcome in certain matters could, from time to time, have a material adverse effect on the Company's consolidated financial condition or results of operations in particular quarterly or annual periods. |
Subsequent_Events
Subsequent Events | 6 Months Ended |
Mar. 31, 2014 | |
Subsequent Events [Abstract] | ' |
Subsequent Events | ' |
Subsequent Event | |
On April 30, 2014, the Company acquired all of the outstanding stock of DMS Dynamic Micro Systems Semiconductor Equipment GmbH (“DMS”), a German based provider of logistic solutions for semiconductor fabrication plants. The Company agreed to a purchase price of $31.0 million, subject to a working capital adjustment expected to be concluded within 90 days of closing. The aggregate merger consideration includes approximately $16.0 million related to the repayment of DMS’s debt obligations. The acquisition of DMS provides the Company with the opportunity to enhance its existing capabilities with respect to automation solutions in the semiconductor front-end market. | |
On May 7, 2014, the Company’s Board of Directors declared a cash dividend of $0.08 per share payable on June 27, 2014 to common stockholders of record on June 6, 2014. Dividends are declared at the discretion of the Company’s Board of Directors and depend on actual cash from operations, the Company’s financial condition and capital requirements and any other factors the Company’s Board of Directors may consider relevant. Future dividend declarations, as well as the record and payment dates for such dividends, will be determined by the Company’s Board of Directors on a quarterly basis. |
StockBased_Compensation_Tables
Stock-Based Compensation (Tables) | 6 Months Ended | |||||||||||||||
Mar. 31, 2014 | ||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||||||||||||
Stock-Based Compensation Expense | ' | |||||||||||||||
The following table reflects stock-based compensation expense, excluding amounts related to discontinued operations, recorded during the three and six months ended March 31, 2014 and 2013 (in thousands): | ||||||||||||||||
Three months ended | Six months ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Restricted stock | $ | 3,683 | $ | 2,341 | $ | 6,293 | $ | 4,672 | ||||||||
Employee stock purchase plan | 112 | 117 | 225 | 244 | ||||||||||||
$ | 3,795 | $ | 2,458 | $ | 6,518 | $ | 4,916 | |||||||||
Stock Option Activity | ' | |||||||||||||||
The following table summarizes stock option activity for the six months ended March 31, 2014: | ||||||||||||||||
Number of | Weighted- | Weighted | Aggregate | |||||||||||||
Options | Average | Average | Intrinsic Value | |||||||||||||
Remaining | Exercise Price | (In Thousands) | ||||||||||||||
Contractual Term | ||||||||||||||||
Outstanding at September 30, 2013 | 15,540 | $ | 15.86 | |||||||||||||
Outstanding at March 31, 2014 | 15,540 | 0.3 years | $ | 15.86 | $ | — | ||||||||||
Vested at March 31, 2014 | 15,540 | 0.3 years | $ | 15.86 | $ | — | ||||||||||
Options exercisable at March 31, 2014 | 15,540 | 0.3 years | $ | 15.86 | $ | — | ||||||||||
Status of Restricted Stock Activity and Changes | ' | |||||||||||||||
The following table summarizes restricted stock activity for the six months ended March 31, 2014: | ||||||||||||||||
Shares | Weighted | |||||||||||||||
Average | ||||||||||||||||
Grant-Date | ||||||||||||||||
Fair Value | ||||||||||||||||
Outstanding at September 30, 2013 | 2,915,413 | $ | 11.25 | |||||||||||||
Awards granted | 1,409,557 | 9.46 | ||||||||||||||
Awards vested | (522,023 | ) | 9.37 | |||||||||||||
Awards canceled | (767,962 | ) | 10.63 | |||||||||||||
Outstanding at March 31, 2014 | 3,034,985 | $ | 10.9 | |||||||||||||
Acquisition_Tables
Acquisition (Tables) | 6 Months Ended | |||
Mar. 31, 2014 | ||||
Business Combinations [Abstract] | ' | |||
Amounts of Assets and Liabilities at Fair Value as of Acquisition Date | ' | |||
The Company recorded the assets and liabilities associated with Crossing at their fair values as of the acquisition date. The amounts recorded were as follows (in thousands): | ||||
Accounts receivable | $ | 5,356 | ||
Inventory | 8,668 | |||
Prepaid expenses | 1,968 | |||
Property, plant and equipment | 2,270 | |||
Completed technology | 10,530 | |||
Customer relationships | 20,010 | |||
Goodwill | 26,453 | |||
Other long term assets | 885 | |||
Accounts payable | (3,024 | ) | ||
Accrued liabilities | (5,172 | ) | ||
Deferred revenue | (319 | ) | ||
Other current liabilities | (388 | ) | ||
Other long-term liabilities | (8,232 | ) | ||
Total purchase price, net of cash acquired | $ | 59,005 | ||
The Company recorded the assets and liabilities associated with the purchase of the Acquired assets at their fair values as of the acquisition date. The amounts recorded were as follows (in thousands): | ||||
Accounts receivable | $ | 636 | ||
Inventory | 2,095 | |||
Prepaid and other current assets | 103 | |||
Property, plant and equipment | 534 | |||
Completed technology | 500 | |||
Customer relationships | 1,500 | |||
Goodwill | 7,076 | |||
Debt | (902 | ) | ||
Accounts payable | (294 | ) | ||
Deferred revenue | (351 | ) | ||
Customer deposits | (1,249 | ) | ||
Other current liabilities | (322 | ) | ||
Total purchase price, net of cash acquired | $ | 9,326 | ||
Discontinued_Operations_Tables
Discontinued Operations (Tables) | 6 Months Ended | |||||||||||||||
Mar. 31, 2014 | ||||||||||||||||
Discontinued Operations and Disposal Groups [Abstract] | ' | |||||||||||||||
Schedules of Discontinued Operations | ' | |||||||||||||||
Summarized results of the discontinued operation are as follows (in thousands): | ||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Revenue | $ | 7,453 | $ | 7,137 | $ | 14,968 | $ | 13,656 | ||||||||
Income from discontinued operations | $ | 1,825 | $ | 2,198 | $ | 4,309 | $ | 3,602 | ||||||||
Income tax provision (benefit) | 663 | (456 | ) | 1,570 | (240 | ) | ||||||||||
Income from discontinued operations, net of tax | $ | 1,162 | $ | 2,654 | $ | 2,739 | $ | 3,842 | ||||||||
The major classes of assets and liabilities of the discontinued operation as are follows (in thousands): | ||||||||||||||||
March 31, | September 30, | |||||||||||||||
2014 | 2013 | |||||||||||||||
Inventory | $ | 3,602 | $ | 3,308 | ||||||||||||
Property, plant and equipment | 315 | 364 | ||||||||||||||
Goodwill | 24,106 | 24,106 | ||||||||||||||
Assets held for sale | $ | 28,023 | $ | 27,778 | ||||||||||||
Deferred revenue | $ | 21 | $ | 43 | ||||||||||||
Accrued warranty and retrofit costs | 86 | 89 | ||||||||||||||
Liabilities held for sale | $ | 107 | $ | 132 | ||||||||||||
Goodwill_and_Intangible_Assets1
Goodwill and Intangible Assets (Tables) | 6 Months Ended | |||||||||||||||||||||||
Mar. 31, 2014 | ||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ' | |||||||||||||||||||||||
Components of Goodwill by Business Segment | ' | |||||||||||||||||||||||
The components of the Company’s goodwill, excluding amounts related to the discontinued operations, by business segment at March 31, 2014 are as follows (in thousands): | ||||||||||||||||||||||||
Brooks | Brooks | Brooks | Other | Total | ||||||||||||||||||||
Product | Global | Life Science | ||||||||||||||||||||||
Solutions | Services | Systems | ||||||||||||||||||||||
Gross goodwill at September 30, 2013 | $ | 482,637 | $ | 156,792 | $ | 47,439 | $ | 26,014 | $ | 712,882 | ||||||||||||||
Less: aggregate impairment charges recorded | (437,706 | ) | (151,238 | ) | — | (26,014 | ) | (614,958 | ) | |||||||||||||||
Goodwill, less accumulated impairments at September 30, 2013 | 44,931 | 5,554 | 47,439 | — | 97,924 | |||||||||||||||||||
Adjustments during the six months ended March 31, 2014 | — | — | (61 | ) | — | (61 | ) | |||||||||||||||||
Goodwill, less accumulated impairments at March 31, 2014 | $ | 44,931 | $ | 5,554 | $ | 47,378 | $ | — | $ | 97,863 | ||||||||||||||
Components of Identifiable Intangible Assets | ' | |||||||||||||||||||||||
Components of the Company’s identifiable intangible assets, excluding amounts related to the discontinued operations, are as follows (in thousands): | ||||||||||||||||||||||||
31-Mar-14 | September 30, 2013 | |||||||||||||||||||||||
Cost | Accumulated | Net Book | Cost | Accumulated | Net Book | |||||||||||||||||||
Amortization | Value | Amortization | Value | |||||||||||||||||||||
Patents | $ | 7,808 | $ | 7,248 | $ | 560 | $ | 7,808 | $ | 7,196 | $ | 612 | ||||||||||||
Completed technology | 53,557 | 39,211 | 14,346 | 57,050 | 40,354 | 16,696 | ||||||||||||||||||
Trademarks and trade names | 3,496 | 3,496 | — | 3,564 | 3,554 | 10 | ||||||||||||||||||
Customer relationships | 67,134 | 26,916 | 40,218 | 66,687 | 23,917 | 42,770 | ||||||||||||||||||
$ | 131,995 | $ | 76,871 | $ | 55,124 | $ | 135,109 | $ | 75,021 | $ | 60,088 | |||||||||||||
Earnings_per_Share_Tables
Earnings per Share (Tables) | 6 Months Ended | |||||||||||
Mar. 31, 2014 | ||||||||||||
Earnings Per Share [Abstract] | ' | |||||||||||
Reconciliation of Weighted Average Common Shares Outstanding for Purposes of Calculating Basic and Diluted Earnings Per Share | ' | |||||||||||
Below is a reconciliation of weighted average common shares outstanding for purposes of calculating basic and diluted earnings per share (in thousands): | ||||||||||||
Three months ended | Six months ended | |||||||||||
March 31, | March 31, | |||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||
Weighted average common shares outstanding used in computing basic earnings per share | 66,646 | 65,889 | 66,499 | 65,726 | ||||||||
Dilutive common stock options and restricted stock awards | 859 | — | 884 | — | ||||||||
Weighted average common shares outstanding for purposes of computing diluted earnings per share | 67,505 | 65,889 | 67,383 | 65,726 | ||||||||
Segment_Information_Tables
Segment Information (Tables) | 6 Months Ended | |||||||||||||||
Mar. 31, 2014 | ||||||||||||||||
Segment Reporting [Abstract] | ' | |||||||||||||||
Financial Information for Business Segments | ' | |||||||||||||||
Financial information for the Company’s business segments, excluding amounts related to the discontinued operations, is as follows (in thousands): | ||||||||||||||||
Brooks | Brooks | Brooks | Total | |||||||||||||
Product | Global | Life Science | ||||||||||||||
Solutions | Services | Systems | ||||||||||||||
Three months ended March 31, 2014 | ||||||||||||||||
Revenue | ||||||||||||||||
Product | $ | 89,897 | $ | 4,213 | $ | 8,424 | $ | 102,534 | ||||||||
Services | — | 19,178 | 4,188 | 23,366 | ||||||||||||
$ | 89,897 | $ | 23,391 | $ | 12,612 | $ | 125,900 | |||||||||
Gross profit | $ | 31,960 | $ | 7,676 | $ | 4,662 | $ | 44,298 | ||||||||
Segment operating income (loss) | $ | 6,127 | $ | 2,248 | $ | (3,565 | ) | $ | 4,810 | |||||||
Three months ended March 31, 2013 | ||||||||||||||||
Revenue | ||||||||||||||||
Product | $ | 78,563 | $ | 3,731 | $ | 6,358 | $ | 88,652 | ||||||||
Services | — | 18,073 | 2,757 | 20,830 | ||||||||||||
$ | 78,563 | $ | 21,804 | $ | 9,115 | $ | 109,482 | |||||||||
Gross profit | $ | 24,313 | $ | 6,359 | $ | 2,411 | $ | 33,083 | ||||||||
Segment operating income (loss) | $ | 1,464 | $ | 1,799 | $ | (3,875 | ) | $ | (612 | ) | ||||||
Six months ended March 31, 2014 | ||||||||||||||||
Revenue | ||||||||||||||||
Product | $ | 171,453 | $ | 7,652 | $ | 16,559 | $ | 195,664 | ||||||||
Services | — | 39,058 | 8,250 | 47,308 | ||||||||||||
$ | 171,453 | $ | 46,710 | $ | 24,809 | $ | 242,972 | |||||||||
Gross profit | $ | 60,461 | $ | 15,501 | $ | 9,227 | $ | 85,189 | ||||||||
Segment operating income (loss) | $ | 10,455 | $ | 5,091 | $ | (7,040 | ) | $ | 8,506 | |||||||
Six months ended March 31 2013 | ||||||||||||||||
Revenue | ||||||||||||||||
Product | $ | 134,990 | $ | 7,236 | $ | 17,454 | $ | 159,680 | ||||||||
Services | — | 35,509 | 5,799 | 41,308 | ||||||||||||
$ | 134,990 | $ | 42,745 | $ | 23,253 | $ | 200,988 | |||||||||
Gross profit | $ | 39,293 | $ | 11,366 | $ | 8,705 | $ | 59,364 | ||||||||
Segment operating income (loss) | $ | (6,447 | ) | $ | 2,287 | $ | (3,897 | ) | $ | (8,057 | ) | |||||
Assets | ||||||||||||||||
31-Mar-14 | $ | 231,324 | $ | 61,856 | $ | 107,933 | $ | 401,113 | ||||||||
September 30, 2013 | $ | 226,759 | $ | 59,762 | $ | 105,221 | $ | 391,742 | ||||||||
Reconciliation of Reportable Segment Operating Income (Loss) to Corresponding Consolidated Amounts | ' | |||||||||||||||
A reconciliation of the Company’s reportable segment operating income (loss) to the corresponding consolidated amounts for the three and six month periods ended March 31, 2014 and 2013 is as follows (in thousands): | ||||||||||||||||
Three months ended | Six months ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Segment operating income (loss) | $ | 4,810 | $ | (612 | ) | $ | 8,506 | $ | (8,057 | ) | ||||||
Amortization of acquired intangible assets | 1,460 | 1,413 | 2,916 | 2,856 | ||||||||||||
Restructuring and other charges | 772 | 751 | 1,519 | 5,441 | ||||||||||||
Other unallocated corporate expenses | 182 | 394 | 217 | 1,284 | ||||||||||||
Total operating income (loss) | $ | 2,396 | $ | (3,170 | ) | $ | 3,854 | $ | (17,638 | ) | ||||||
Reconciliation of Reportable Segment Assets to Corresponding Consolidated Amounts | ' | |||||||||||||||
A reconciliation of the Company’s reportable segment assets to the corresponding consolidated amounts as of March 31, 2014 and September 30, 2013 is as follows (in thousands): | ||||||||||||||||
March 31, | September 30, | |||||||||||||||
2014 | 2013 | |||||||||||||||
Segment assets | $ | 401,113 | $ | 391,742 | ||||||||||||
Cash, cash equivalents, restricted cash and marketable securities | 192,223 | 173,539 | ||||||||||||||
Deferred tax assets | 113,504 | 115,985 | ||||||||||||||
Assets held for sale | 28,023 | 27,778 | ||||||||||||||
Equity method investments | 30,342 | 25,687 | ||||||||||||||
Other unallocated corporate net assets | 2,016 | 2,032 | ||||||||||||||
Total assets | $ | 767,221 | $ | 736,763 | ||||||||||||
Restructuring_and_Other_Charge1
Restructuring and Other Charges (Tables) | 6 Months Ended | |||||||||||||||
Mar. 31, 2014 | ||||||||||||||||
Restructuring and Related Activities [Abstract] | ' | |||||||||||||||
Activity Related to Restructuring Accruals | ' | |||||||||||||||
The activity for the three and six months ended March 31, 2014 and 2013 related to the Company's restructuring-related accruals, excluding amounts related to the discontinued operations, is summarized below (in thousands): | ||||||||||||||||
Activity — Three Months Ended March 31, 2014 | ||||||||||||||||
Balance at | Expense | Utilization | Balance at | |||||||||||||
December 31, | March 31, | |||||||||||||||
2013 | 2014 | |||||||||||||||
Facilities and other | $ | 57 | $ | 7 | $ | (64 | ) | $ | — | |||||||
Workforce-related | 1,405 | 765 | (618 | ) | 1,552 | |||||||||||
$ | 1,462 | $ | 772 | $ | (682 | ) | $ | 1,552 | ||||||||
Activity - Three Months Ended March 31, 2013 | ||||||||||||||||
Balance at | Expense | Utilization | Balance at | |||||||||||||
December 31, | March 31, | |||||||||||||||
2012 | 2013 | |||||||||||||||
Facilities and other | $ | 265 | $ | 112 | $ | (144 | ) | $ | 233 | |||||||
Workforce-related | 4,438 | 639 | (2,746 | ) | 2,331 | |||||||||||
$ | 4,703 | $ | 751 | $ | (2,890 | ) | $ | 2,564 | ||||||||
Activity — Six Months Ended March 31, 2014 | ||||||||||||||||
Balance at | Expense | Utilization | Balance at | |||||||||||||
September 30, | March 31, | |||||||||||||||
2013 | 2014 | |||||||||||||||
Facilities and other | $ | 155 | $ | 13 | $ | (168 | ) | $ | — | |||||||
Workforce-related | 1,257 | 1,506 | (1,211 | ) | 1,552 | |||||||||||
$ | 1,412 | $ | 1,519 | $ | (1,379 | ) | $ | 1,552 | ||||||||
Activity — Six Months Ended March 31, 2013 | ||||||||||||||||
Balance at | Expense | Utilization | Balance at | |||||||||||||
September 30, | March 31, | |||||||||||||||
2012 | 2013 | |||||||||||||||
Facilities and other | $ | — | $ | 690 | $ | (457 | ) | $ | 233 | |||||||
Workforce-related | 2,021 | 4,664 | (4,354 | ) | 2,331 | |||||||||||
$ | 2,021 | $ | 5,354 | $ | (4,811 | ) | $ | 2,564 | ||||||||
Employee_Benefit_Plans_Tables
Employee Benefit Plans (Tables) | 6 Months Ended | |||||||||||||||
Mar. 31, 2014 | ||||||||||||||||
Compensation and Retirement Disclosure [Abstract] | ' | |||||||||||||||
Components of Net Pension Cost | ' | |||||||||||||||
The components of the Company’s net pension cost for the three and six months ended March 31, 2014 and 2013 is as follows (in thousands): | ||||||||||||||||
Three months ended | Six months ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Service cost | $ | 102 | $ | 144 | $ | 202 | $ | 322 | ||||||||
Interest cost | 39 | 35 | 78 | 80 | ||||||||||||
Amortization of losses | — | 1 | 1 | 3 | ||||||||||||
Expected return on assets | (55 | ) | (58 | ) | (108 | ) | (135 | ) | ||||||||
Net periodic pension cost | 86 | 122 | 173 | 270 | ||||||||||||
Settlement loss | — | — | — | 87 | ||||||||||||
Total pension cost | $ | 86 | $ | 122 | $ | 173 | $ | 357 | ||||||||
Capital_Lease_Obligation_Table
Capital Lease Obligation (Tables) | 6 Months Ended | |||
Mar. 31, 2014 | ||||
Leases [Abstract] | ' | |||
Schedule of Future Minimum Lease Payments | ' | |||
The future minimum lease payments required under the capital lease and the present value of the net minimum lease payments, as of March 31, 2014, are as follows (in thousands): | ||||
Year ended September 30, | ||||
2014 | $ | 441 | ||
2015 | 881 | |||
2016 | 881 | |||
2017 | 881 | |||
2018 | 6,901 | |||
Total minimum lease payments | 9,985 | |||
Less amounts representing interest | 1,448 | |||
Total capital lease obligation | 8,537 | |||
Less current portion of capital lease obligation | 881 | |||
Long-term capital lease obligation | $ | 7,656 | ||
Other_Balance_Sheet_Informatio1
Other Balance Sheet Information (Tables) | 6 Months Ended | ||||||||||||||||||
Mar. 31, 2014 | |||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' | ||||||||||||||||||
Summary of Accounts Receivable | ' | ||||||||||||||||||
The following is a summary of accounts receivable at March 31, 2014 and September 30, 2013 (in thousands): | |||||||||||||||||||
March 31, | September 30, | ||||||||||||||||||
2014 | 2013 | ||||||||||||||||||
Accounts receivable | $ | 84,770 | $ | 78,460 | |||||||||||||||
Less allowance for doubtful accounts | (1,184 | ) | (863 | ) | |||||||||||||||
Less allowance for sales returns | (146 | ) | (114 | ) | |||||||||||||||
$ | 83,440 | $ | 77,483 | ||||||||||||||||
Summary of Inventories | ' | ||||||||||||||||||
The following is a summary of inventories at March 31, 2014 and September 30, 2013, excluding amounts related to the discontinued operations (in thousands): | |||||||||||||||||||
March 31, | September 30, | ||||||||||||||||||
2014 | 2013 | ||||||||||||||||||
Inventories | |||||||||||||||||||
Raw materials and purchased parts | $ | 59,844 | $ | 57,678 | |||||||||||||||
Work-in-process | 17,083 | 19,991 | |||||||||||||||||
Finished goods | 16,823 | 16,742 | |||||||||||||||||
$ | 93,750 | $ | 94,411 | ||||||||||||||||
Product Warranty and Retrofit Activity on Gross Basis | ' | ||||||||||||||||||
Product warranty and retrofit activity on a gross basis for the three and six months ended March 31, 2014 and 2013, excluding amounts related to the discontinued operations, is as follows (in thousands): | |||||||||||||||||||
Activity - Three Months Ended March 31, 2014 | |||||||||||||||||||
Balance at | Adjustments for | Accruals | Costs Incurred | Balance at | |||||||||||||||
December 31, | Acquisitions and Divestitures | March 31, | |||||||||||||||||
2013 | 2014 | ||||||||||||||||||
$ | 6,762 | $ | — | $ | 2,275 | $ | (2,718 | ) | $ | 6,319 | |||||||||
Activity - Three Months Ended March 31, 2013 | |||||||||||||||||||
Balance at | Adjustments for | Accruals | Costs Incurred | Balance at | |||||||||||||||
December 31, | Acquisitions and Divestitures | March 31, | |||||||||||||||||
2012 | 2013 | ||||||||||||||||||
$ | 7,637 | $ | — | $ | 2,985 | $ | (2,987 | ) | $ | 7,635 | |||||||||
Activity - Six Months Ended March 31, 2014 | |||||||||||||||||||
Balance at | Adjustments for | Accruals | Costs Incurred | Balance at | |||||||||||||||
September 30, | Acquisitions and Divestitures | March 31, | |||||||||||||||||
2013 | 2014 | ||||||||||||||||||
$ | 7,260 | $ | — | $ | 4,150 | $ | (5,091 | ) | $ | 6,319 | |||||||||
Activity - Six Months Ended March 31, 2013 | |||||||||||||||||||
Balance at | Adjustments for | Accruals | Costs Incurred | Balance at | |||||||||||||||
September 30, | Acquisitions and Divestitures | March 31, | |||||||||||||||||
2012 | 2013 | ||||||||||||||||||
$ | 7,246 | $ | 962 | $ | 5,317 | $ | (5,890 | ) | $ | 7,635 | |||||||||
Derivative_Instruments_Tables
Derivative Instruments (Tables) | 6 Months Ended | ||||||||||||||||||||
Mar. 31, 2014 | |||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ' | ||||||||||||||||||||
Notional Amounts Outstanding under Foreign Currency Contracts | ' | ||||||||||||||||||||
The Company had the following notional amounts outstanding under foreign currency contracts that qualify for cash flow hedge accounting at March 31, 2014 (in thousands): | |||||||||||||||||||||
Buy Currency | Notional Amount | Sell Currency | Maturity | Notional Amount | Fair Value of | Fair Value of | |||||||||||||||
of Buy Currency in U.S. Dollars | of Sell Currency | Assets | Liabilities | ||||||||||||||||||
in U.S. Dollars | |||||||||||||||||||||
U.S. Dollar | $ | 2,037 | Japanese Yen | Apr-14 | $ | 1,946 | $ | 91 | $ | — | |||||||||||
The Company had the following notional amounts outstanding under foreign currency contracts that do not qualify for hedge accounting at March 31, 2014 and September 30, 2013 (in thousands): | |||||||||||||||||||||
March 31, 2014: | |||||||||||||||||||||
Buy Currency | Notional Amount | Sell Currency | Maturity | Notional Amount | Fair Value of | Fair Value of | |||||||||||||||
of Buy Currency | of Sell Currency | Assets | Liabilities | ||||||||||||||||||
in U.S. Dollars | |||||||||||||||||||||
U.S. Dollar | $ | 2,976 | Japanese Yen | April to June 2014 | $ | 2,973 | $ | 3 | $ | — | |||||||||||
British Pound | 2,470 | Euro | April 2014 | 2,488 | — | (18 | ) | ||||||||||||||
U.S. Dollar | 698 | Taiwan Dollar | April 2014 | 697 | 1 | — | |||||||||||||||
Korean Won | 605 | U.S. Dollar | April 2014 | 602 | 3 | — | |||||||||||||||
U.S. Dollar | 428 | Israeli Shekel | April 2014 | 431 | — | (3 | ) | ||||||||||||||
$ | 7,177 | $ | 7,191 | $ | 7 | $ | (21 | ) | |||||||||||||
September 30, 2013: | |||||||||||||||||||||
Buy Currency | Notional Amount | Sell Currency | Maturity | Notional Amount | Fair Value of | Fair Value of | |||||||||||||||
of Buy Currency in U.S. Dollars | of Sell Currency | Assets | Liabilities | ||||||||||||||||||
in U.S. Dollars | |||||||||||||||||||||
U.S. Dollar | $ | 2,770 | Japanese Yen | October 2013 to December 2013 | $ | 2,762 | $ | 8 | $ | — | |||||||||||
Korean Won | 686 | U.S. Dollar | October 2013 | 688 | — | 2 | |||||||||||||||
U.S. Dollar | 301 | Israeli Shekel | October 2013 | 304 | — | 3 | |||||||||||||||
U.S. Dollar | 231 | Singapore Dollar | October 2013 | 231 | — | — | |||||||||||||||
$ | 3,988 | $ | 3,985 | $ | 8 | $ | 5 | ||||||||||||||
Schedule of Net Gains and Losses Realized on Derivative Instruments | ' | ||||||||||||||||||||
Net gains and losses recorded as a component of Other Income (Expense), net in the Consolidated Statements of Operations related to these contracts for the three and six month periods ended March 31, 2014 and 2013 is as follows (in thousands): | |||||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||||
March 31, | March 31, | ||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||||||
Realized gains (losses) on derivative instruments not designated as hedging instruments | $ | (0.2 | ) | $ | 0.1 | $ | (0.1 | ) | $ | 0.1 | |||||||||||
Marketable_Securities_Tables
Marketable Securities (Tables) | 6 Months Ended | |||||||||||||||
Mar. 31, 2014 | ||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | ' | |||||||||||||||
Summary of Marketable Securities Including Accrued Interest Receivable | ' | |||||||||||||||
The following is a summary of marketable securities (included in short and long-term marketable securities in the Consolidated Balance Sheets), including accrued interest receivable, as of March 31, 2014 and September 30, 2013 (in thousands): | ||||||||||||||||
Amortized | Gross | Gross | Fair Value | |||||||||||||
Cost | Unrealized | Unrealized | ||||||||||||||
Gains | Losses | |||||||||||||||
March 31, 2014: | ||||||||||||||||
U.S. Treasury securities and obligations of U.S. government agencies | $ | 15,876 | $ | 3 | $ | (35 | ) | $ | 15,844 | |||||||
Corporate securities | 53,419 | 36 | (30 | ) | 53,425 | |||||||||||
Mortgage-backed securities | 1,035 | 31 | — | 1,066 | ||||||||||||
Other debt securities | 899 | — | — | 899 | ||||||||||||
Municipal securities | 23,882 | 11 | (9 | ) | 23,884 | |||||||||||
Bank certificate of deposits | 11,823 | 1 | — | 11,824 | ||||||||||||
$ | 106,934 | $ | 82 | $ | (74 | ) | $ | 106,942 | ||||||||
September 30, 2013: | ||||||||||||||||
U.S. Treasury securities and obligations of U.S. government agencies | $ | 19,528 | $ | 6 | $ | (13 | ) | $ | 19,521 | |||||||
Corporate securities | 35,045 | 11 | (47 | ) | 35,009 | |||||||||||
Mortgage-backed securities | 1,093 | 25 | (1 | ) | 1,117 | |||||||||||
Other debt securities | 88 | — | — | 88 | ||||||||||||
Municipal securities | 25,199 | 15 | (7 | ) | 25,207 | |||||||||||
Bank certificate of deposits | 9,451 | — | (2 | ) | 9,449 | |||||||||||
$ | 90,404 | $ | 57 | $ | (70 | ) | $ | 90,391 | ||||||||
Fair Value of Marketable Securities by Contractual Maturity | ' | |||||||||||||||
The fair value of the marketable securities at March 31, 2014 by contractual maturity, are shown below (in thousands). Expected maturities could differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties. | ||||||||||||||||
Fair Value | ||||||||||||||||
Due in one year or less | $ | 50,274 | ||||||||||||||
Due after one year through five years | 53,291 | |||||||||||||||
Due after ten years | 3,377 | |||||||||||||||
$ | 106,942 | |||||||||||||||
Fair_Value_Measurements_Tables
Fair Value Measurements (Tables) | 6 Months Ended | ||||||||||||||||
Mar. 31, 2014 | |||||||||||||||||
Fair Value Disclosures [Abstract] | ' | ||||||||||||||||
Assets and Liabilities Measured at Fair Value on Recurring Basis | ' | ||||||||||||||||
Assets and liabilities of the Company measured at fair value on a recurring basis as of March 31, 2014 and September 30, 2013 are summarized as follows (in thousands): | |||||||||||||||||
Fair Value Measurements at Reporting Date Using | |||||||||||||||||
Description | March 31, | Quoted Prices in | Significant Other | Significant | |||||||||||||
2014 | Active Markets for | Observable Inputs | Unobservable Inputs | ||||||||||||||
Identical Assets | (Level 2) | (Level 3) | |||||||||||||||
(Level 1) | |||||||||||||||||
Assets | |||||||||||||||||
Cash equivalents | $ | 6,532 | $ | 16 | $ | 6,516 | $ | — | |||||||||
Available-for-sale securities | 106,942 | — | 106,942 | — | |||||||||||||
Foreign exchange contracts | 98 | — | 98 | — | |||||||||||||
Total Assets | $ | 113,572 | $ | 16 | $ | 113,556 | $ | — | |||||||||
Liabilities | |||||||||||||||||
Foreign exchange contracts | $ | 21 | $ | — | $ | 21 | $ | — | |||||||||
Fair Value Measurements at Reporting Date Using | |||||||||||||||||
Description | September 30, | Quoted Prices in | Significant Other | Significant | |||||||||||||
2013 | Active Markets for | Observable Inputs | Unobservable Inputs | ||||||||||||||
Identical Assets | (Level 2) | (Level 3) | |||||||||||||||
(Level 1) | |||||||||||||||||
Assets | |||||||||||||||||
Cash equivalents | $ | 7,754 | $ | 6,152 | $ | 1,602 | $ | — | |||||||||
Available-for-sale securities | 90,391 | 2,199 | 88,192 | — | |||||||||||||
Foreign exchange contracts | 31 | — | 31 | — | |||||||||||||
Total Assets | $ | 98,176 | $ | 8,351 | $ | 89,825 | $ | — | |||||||||
Liabilities | |||||||||||||||||
Foreign exchange contracts | $ | 5 | $ | — | $ | 5 | $ | — | |||||||||
StockBased_Compensation_Narrat
Stock-Based Compensation Narrative (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Total compensation expense on awards | ' | ' | $6,516,000 | $5,010,000 |
Closing stock price | $10.93 | ' | $10.93 | ' |
Total intrinsic value of options exercised | ' | 19,000 | ' | 19,000 |
Proceeds from stock options exercised | ' | 67,000 | ' | 67,000 |
Stock purchase under employee stock purchase plan | 115,132 | 115,751 | 115,132 | 115,751 |
Proceeds from issuance of shares under ESPP | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 |
Restricted Stock | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Restricted stocks granted | ' | ' | 1,409,557 | ' |
Fair value of restricted stock awards vested | 1,800,000 | 3,100,000 | 4,900,000 | 6,000,000 |
Unrecognized compensation cost | 15,700,000 | ' | 15,700,000 | ' |
Unrecognized compensation cost, estimated weighted average amortization period | '1 year 10 months | ' | ' | ' |
Restricted Stock | Senior Management | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Restricted stocks granted | ' | ' | 1,409,557 | 1,224,000 |
Restricted Stock | Senior Management | Maximum | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Total compensation expense on awards | $19,200,000 | $7,300,000 | ' | ' |
Restricted Stock | Senior Management | Awards Subject to Service Criteria | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Restricted stocks granted | ' | ' | 601,432 | 546,625 |
Restricted Stock | Senior Management | Awards Subject to Performance Criteria | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Restricted stocks granted | ' | ' | 808,125 | 677,375 |
Grants earned in period | ' | ' | ' | 460,615 |
Granville-Phillips [Member] | Restricted Stock | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Restricted stocks granted | ' | ' | 8,500 | 29,380 |
StockBased_Compensation_StockB
Stock-Based Compensation Stock-Based Compensation Expense (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Stock-based compensation | ' | ' | $6,516 | $5,010 |
Continuing Operations | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Stock-based compensation | 3,795 | 2,458 | 6,518 | 4,916 |
Continuing Operations | Restricted Stock | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Stock-based compensation | 3,683 | 2,341 | 6,293 | 4,672 |
Continuing Operations | Employee Stock Purchase Plan | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Stock-based compensation | $112 | $117 | $225 | $244 |
StockBased_Compensation_Stock_
Stock-Based Compensation Stock Option Activity (Detail) (USD $) | 6 Months Ended |
In Thousands, except Share data, unless otherwise specified | Mar. 31, 2014 |
Number of Stock Options | ' |
Options outstanding at beginning of period (shares) | 15,540 |
Options outstanding at end of period (shares) | 15,540 |
Vested at end of period (shares) | 15,540 |
Options exercisable at end of period (shares) | 15,540 |
Weighted-Average Remaining Contractual Term | ' |
Options outstanding at end of period | '4 months |
Vested at end of period | '4 months |
Options exercisable at end of period | '4 months |
Weighted Average Exercise Price | ' |
Options outstanding at beginning of period (USD per share) | $15.86 |
Vested at end of period (USD per share) | $15.86 |
Options outstanding at end of year (USD per share) | $15.86 |
Options exercisable at end of period (USD per share) | $15.86 |
Options outstanding at end of period | $0 |
Vested at end of period | 0 |
Options exercisable at end of period | $0 |
StockBased_Compensation_Status
Stock-Based Compensation Status of Restricted Stock Activity and Changes (Detail) (Restricted Stock, USD $) | 6 Months Ended |
Mar. 31, 2014 | |
Restricted Stock | ' |
Shares | ' |
Outstanding at Beginning of period (shares) | 2,915,413 |
Awards granted (shares) | 1,409,557 |
Awards vested (shares) | -522,023 |
Awards canceled (shares) | -767,962 |
Outstanding at End of period (shares) | 3,034,985 |
Weighted Average Grant-Date Fair Value | ' |
Outstanding at beginning of period (USD per share) | $11.25 |
Awards granted (USD per share) | $9.46 |
Awards vested (USD per share) | $9.37 |
Awards canceled (USD per share) | $10.63 |
Outstanding at end of period (USD per share) | $10.90 |
Acquisition_Narrative_Detail
Acquisition Narrative (Detail) (USD $) | 6 Months Ended | 0 Months Ended | 12 Months Ended | 0 Months Ended | 6 Months Ended | |||
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Aug. 01, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Oct. 29, 2012 | Mar. 31, 2014 | Mar. 31, 2014 |
Matrical | Matrical | Matrical | Crossing Automation Inc | Crossing Automation Inc | Crossing Automation Inc | |||
Completed Technology | Customer Relationships | Completed Technology | Customer Relationships | |||||
Business Acquisition [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' |
Acquisition, net of cash acquired | $0 | $59,005 | $9,326 | ' | ' | $59,005 | ' | ' |
Cash flow discount rate used to determine fair value attributed to completed technologies | ' | ' | 18.00% | ' | ' | ' | 15.00% | ' |
Useful life of intangible assets acquired | ' | ' | ' | '4 years 7 months | '7 years | ' | '7 years 8 months | '8 years |
Discontinued_Operations_Result
Discontinued Operations - Results of Operations (Details) (USD $) | 0 Months Ended | 3 Months Ended | 6 Months Ended | ||
Mar. 19, 2014 | Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ' | ' | ' | ' | ' |
Income from discontinued operations, net of tax | ' | $1,162,000 | $2,654,000 | $2,739,000 | $3,842,000 |
Granville-Phillips [Member] | ' | ' | ' | ' | ' |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ' | ' | ' | ' | ' |
Agreed upon sales price | 87,000,000 | ' | ' | ' | ' |
Revenue | ' | 7,453,000 | 7,137,000 | 14,968,000 | 13,656,000 |
Income from discontinued operations | ' | 1,825,000 | 2,198,000 | 4,309,000 | 3,602,000 |
Income tax provision (benefit) | ' | 663,000 | -456,000 | 1,570,000 | -240,000 |
Income from discontinued operations, net of tax | ' | $1,162,000 | $2,654,000 | $2,739,000 | $3,842,000 |
Acquisition_Amounts_of_Assets_
Acquisition Amounts of Assets and Liabilities at Fair Value as of Acquisition Date (Detail) (USD $) | 6 Months Ended | 0 Months Ended | 0 Months Ended | ||||||
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Sep. 30, 2013 | Aug. 01, 2013 | Aug. 01, 2013 | Aug. 01, 2013 | Oct. 29, 2012 | Oct. 29, 2012 | Oct. 29, 2012 |
Matrical | Matrical | Matrical | Crossing Automation Inc | Crossing Automation Inc | Crossing Automation Inc | ||||
Completed Technology | Customer Relationships | Completed Technology | Customer Relationships | ||||||
Business Acquisition [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Accounts receivable | ' | ' | ' | $636 | ' | ' | $5,356 | ' | ' |
Inventory | ' | ' | ' | 2,095 | ' | ' | 8,668 | ' | ' |
Prepaid and other current assets | ' | ' | ' | 103 | ' | ' | 1,968 | ' | ' |
Property, plant and equipment | ' | ' | ' | 534 | ' | ' | 2,270 | ' | ' |
Finite-lived intangibles | ' | ' | ' | ' | 500 | 1,500 | ' | 10,530 | 20,010 |
Goodwill | 97,863 | ' | 97,924 | 7,076 | ' | ' | 26,453 | ' | ' |
Other long term assets | ' | ' | ' | ' | ' | ' | 885 | ' | ' |
Debt | ' | ' | ' | -902 | ' | ' | ' | ' | ' |
Accounts payable | ' | ' | ' | -294 | ' | ' | -3,024 | ' | ' |
Accrued liabilities | ' | ' | ' | ' | ' | ' | -5,172 | ' | ' |
Deferred revenue | ' | ' | ' | -351 | ' | ' | -319 | ' | ' |
Customer deposits | ' | ' | ' | -1,249 | ' | ' | ' | ' | ' |
Other current liabilities | ' | ' | ' | -322 | ' | ' | -388 | ' | ' |
Other long-term liabilities | ' | ' | ' | ' | ' | ' | -8,232 | ' | ' |
Total purchase price, net of cash acquired | $0 | $59,005 | ' | $9,326 | ' | ' | $59,005 | ' | ' |
Discontinued_Operations_Schedu
Discontinued Operations - Schedule of Assets and Liabilities (Details) (Granville-Phillips [Member], USD $) | Mar. 31, 2014 | Sep. 30, 2013 |
In Thousands, unless otherwise specified | ||
Granville-Phillips [Member] | ' | ' |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ' | ' |
Inventory | $3,602 | $3,308 |
Property, plant and equipment | 315 | 364 |
Goodwill | 24,106 | 24,106 |
Assets held for sale | 28,023 | 27,778 |
Deferred revenue | 21 | 43 |
Accrued warranty and retrofit costs | 86 | 89 |
Liabilities held for sale | $107 | $132 |
Goodwill_and_Intangible_Assets2
Goodwill and Intangible Assets Components of Goodwill by Business Segment (Detail) (USD $) | 6 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2014 | Sep. 30, 2013 |
Goodwill [Line Items] | ' | ' |
Gross goodwill at beginning of period | ' | $712,882 |
Less: aggregate impairment charges recorded | ' | -614,958 |
Goodwill [Roll Forward] | ' | ' |
Goodwill, less accumulated impairments at beginning of period | 97,924 | ' |
Acquisitions and adjustments during the period | -61 | ' |
Goodwill, less accumulated impairments at end of period | 97,863 | ' |
Brooks Product Solutions | ' | ' |
Goodwill [Line Items] | ' | ' |
Gross goodwill at beginning of period | ' | 482,637 |
Less: aggregate impairment charges recorded | ' | -437,706 |
Goodwill [Roll Forward] | ' | ' |
Goodwill, less accumulated impairments at beginning of period | 44,931 | ' |
Acquisitions and adjustments during the period | 0 | ' |
Goodwill, less accumulated impairments at end of period | 44,931 | ' |
Brooks Global Services | ' | ' |
Goodwill [Line Items] | ' | ' |
Gross goodwill at beginning of period | ' | 156,792 |
Less: aggregate impairment charges recorded | ' | -151,238 |
Goodwill [Roll Forward] | ' | ' |
Goodwill, less accumulated impairments at beginning of period | 5,554 | ' |
Acquisitions and adjustments during the period | 0 | ' |
Goodwill, less accumulated impairments at end of period | 5,554 | ' |
Brooks Life Science Systems | ' | ' |
Goodwill [Line Items] | ' | ' |
Gross goodwill at beginning of period | ' | 47,439 |
Less: aggregate impairment charges recorded | ' | 0 |
Goodwill [Roll Forward] | ' | ' |
Goodwill, less accumulated impairments at beginning of period | 47,439 | ' |
Acquisitions and adjustments during the period | -61 | ' |
Goodwill, less accumulated impairments at end of period | 47,378 | ' |
Other | ' | ' |
Goodwill [Line Items] | ' | ' |
Gross goodwill at beginning of period | ' | 26,014 |
Less: aggregate impairment charges recorded | ' | -26,014 |
Goodwill [Roll Forward] | ' | ' |
Goodwill, less accumulated impairments at beginning of period | 0 | ' |
Acquisitions and adjustments during the period | 0 | ' |
Goodwill, less accumulated impairments at end of period | $0 | ' |
Goodwill_and_Intangible_Assets3
Goodwill and Intangible Assets Components of Identifiable Intangible Assets (Detail) (USD $) | Mar. 31, 2014 | Sep. 30, 2013 |
In Thousands, unless otherwise specified | ||
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Cost | $131,995 | $135,109 |
Accumulated Amortization | 76,871 | 75,021 |
Net Book Value | 55,124 | 60,088 |
Patents | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Cost | 7,808 | 7,808 |
Accumulated Amortization | 7,248 | 7,196 |
Net Book Value | 560 | 612 |
Completed Technology | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Cost | 53,557 | 57,050 |
Accumulated Amortization | 39,211 | 40,354 |
Net Book Value | 14,346 | 16,696 |
Trademarks and Trade Names | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Cost | 3,496 | 3,564 |
Accumulated Amortization | 3,496 | 3,554 |
Net Book Value | 0 | 10 |
Customer Relationships | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Cost | 67,134 | 66,687 |
Accumulated Amortization | 26,916 | 23,917 |
Net Book Value | $40,218 | $42,770 |
Goodwill_and_Intangible_Assets4
Goodwill and Intangible Assets Narrative (Details) (USD $) | 6 Months Ended | 3 Months Ended | 12 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Dec. 31, 2013 | Sep. 30, 2013 |
Celigo Cell Cytometer Product Line | Celigo Cell Cytometer Product Line | |||
Goodwill [Line Items] | ' | ' | ' | ' |
Impairment of assets | $398 | $0 | $400 | $2,000 |
Income_Taxes_Narrative_Detail
Income Taxes Narrative (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 | |
Income Tax Contingency [Line Items] | ' | ' | ' | ' |
Income tax provision (benefit) | $1,117,000 | $327,000 | $1,910,000 | ($3,559,000) |
Minimum | ' | ' | ' | ' |
Income Tax Contingency [Line Items] | ' | ' | ' | ' |
Anticipated unrecognized tax benefit reduction during next twelve months | 1,700,000 | ' | 1,700,000 | ' |
Maximum | ' | ' | ' | ' |
Income Tax Contingency [Line Items] | ' | ' | ' | ' |
Anticipated unrecognized tax benefit reduction during next twelve months | $2,800,000 | ' | $2,800,000 | ' |
Earnings_per_Share_Reconciliat
Earnings per Share Reconciliation of Weighted Average Common Shares Outstanding for Purposes of Calculating Basic and Diluted Earnings Per Share (Detail) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 |
Earnings Per Share [Abstract] | ' | ' | ' | ' |
Weighted average common shares outstanding used in computing basic earnings per share | 66,646 | 65,889 | 66,499 | 65,726 |
Dilutive common stock options and restricted stock awards | 859 | 0 | 884 | 0 |
Weighted average common shares outstanding for purposes of computing diluted earnings per share | 67,505 | 65,889 | 67,383 | 65,726 |
Earnings_per_Share_Narrative_D
Earnings per Share Narrative (Detail) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 |
Stock Options | ' | ' | ' | ' |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ' | ' | ' | ' |
Anti-dilutive securities excluded from computation of diluted earnings per share | 16 | 34 | 16 | 65 |
Restricted Stock | ' | ' | ' | ' |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ' | ' | ' | ' |
Anti-dilutive securities excluded from computation of diluted earnings per share | 0 | 3,179 | 0 | 3,008 |
Segment_Information_Narrative_
Segment Information Narrative (Detail) | 6 Months Ended |
Mar. 31, 2014 | |
segment | |
Segment Reporting [Abstract] | ' |
Number of reportable segments | 3 |
Segment_Information_Financial_
Segment Information Financial Information for Business Segments (Detail) (USD $) | 3 Months Ended | 6 Months Ended | |||
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 | Sep. 30, 2013 |
Revenues | ' | ' | ' | ' | ' |
Product | $102,534 | $88,652 | $195,664 | $159,680 | ' |
Services | 23,366 | 20,830 | 47,308 | 41,308 | ' |
Total revenues | 125,900 | 109,482 | 242,972 | 200,988 | ' |
Gross profit | 44,298 | 33,083 | 85,189 | 59,364 | ' |
Segment operating income (loss) | 2,396 | -3,170 | 3,854 | -17,638 | ' |
Total assets | 767,221 | ' | 767,221 | ' | 736,763 |
Brooks Product Solutions | ' | ' | ' | ' | ' |
Revenues | ' | ' | ' | ' | ' |
Product | 89,897 | 78,563 | 171,453 | 134,990 | ' |
Services | 0 | 0 | 0 | 0 | ' |
Total revenues | 89,897 | 78,563 | 171,453 | 134,990 | ' |
Gross profit | 31,960 | 24,313 | 60,461 | 39,293 | ' |
Segment operating income (loss) | 6,127 | 1,464 | 10,455 | -6,447 | ' |
Total assets | 231,324 | ' | 231,324 | ' | 226,759 |
Brooks Global Services | ' | ' | ' | ' | ' |
Revenues | ' | ' | ' | ' | ' |
Product | 4,213 | 3,731 | 7,652 | 7,236 | ' |
Services | 19,178 | 18,073 | 39,058 | 35,509 | ' |
Total revenues | 23,391 | 21,804 | 46,710 | 42,745 | ' |
Gross profit | 7,676 | 6,359 | 15,501 | 11,366 | ' |
Segment operating income (loss) | 2,248 | 1,799 | 5,091 | 2,287 | ' |
Total assets | 61,856 | ' | 61,856 | ' | 59,762 |
Brooks Life Science Systems | ' | ' | ' | ' | ' |
Revenues | ' | ' | ' | ' | ' |
Product | 8,424 | 6,358 | 16,559 | 17,454 | ' |
Services | 4,188 | 2,757 | 8,250 | 5,799 | ' |
Total revenues | 12,612 | 9,115 | 24,809 | 23,253 | ' |
Gross profit | 4,662 | 2,411 | 9,227 | 8,705 | ' |
Segment operating income (loss) | -3,565 | -3,875 | -7,040 | -3,897 | ' |
Total assets | 107,933 | ' | 107,933 | ' | 105,221 |
Operating Segments | ' | ' | ' | ' | ' |
Revenues | ' | ' | ' | ' | ' |
Product | 102,534 | 88,652 | 195,664 | 159,680 | ' |
Services | 23,366 | 20,830 | 47,308 | 41,308 | ' |
Total revenues | 125,900 | 109,482 | 242,972 | 200,988 | ' |
Gross profit | 44,298 | 33,083 | 85,189 | 59,364 | ' |
Segment operating income (loss) | 4,810 | -612 | 8,506 | -8,057 | ' |
Total assets | $401,113 | ' | $401,113 | ' | $391,742 |
Segment_Information_Reconcilia
Segment Information Reconciliation of Reportable Segment Operating Income (Loss) to Corresponding Consolidated Amounts (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 |
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | ' | ' | ' | ' |
Other unallocated corporate expenses | $182 | $394 | $217 | $1,284 |
Amortization of acquired intangible assets | 1,460 | 1,413 | 2,916 | 2,856 |
Restructuring and other charges | 772 | 751 | 1,519 | 5,441 |
Operating income (loss) | 2,396 | -3,170 | 3,854 | -17,638 |
Operating Segments | ' | ' | ' | ' |
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | ' | ' | ' | ' |
Operating income (loss) | $4,810 | ($612) | $8,506 | ($8,057) |
Segment_Information_Reconcilia1
Segment Information Reconciliation of Reportable Segment Assets to Corresponding Consolidated Amounts (Detail) (USD $) | Mar. 31, 2014 | Sep. 30, 2013 |
In Thousands, unless otherwise specified | ||
Segment Reporting, Asset Reconciling Item [Line Items] | ' | ' |
Segment assets | $767,221 | $736,763 |
Investments in cash, cash equivalents, restricted cash and marketable securities | 192,223 | 173,539 |
Deferred tax assets | 113,504 | 115,985 |
Assets held for sale | 28,023 | 27,778 |
Investments in joint ventures | 30,342 | 25,687 |
Other unallocated corporate net assets | 2,016 | 2,032 |
Total assets | 767,221 | 736,763 |
Operating Segments | ' | ' |
Segment Reporting, Asset Reconciling Item [Line Items] | ' | ' |
Segment assets | 401,113 | 391,742 |
Total assets | $401,113 | $391,742 |
Significant_Customers_Narrativ
Significant Customers Narrative (Detail) | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 | |
customer | ||||
Risks and Uncertainties [Abstract] | ' | ' | ' | ' |
Number of major customer by revenue | 1 | ' | ' | ' |
Percentage of revenues from one customer | 10.00% | 13.00% | 12.00% | 11.00% |
Restructuring_and_Other_Charge2
Restructuring and Other Charges Narrative (Detail) (USD $) | 6 Months Ended | |
In Millions, unless otherwise specified | Mar. 31, 2013 | Mar. 31, 2014 |
Polycold Manufacturing Operation | ||
Restructuring Cost and Reserve [Line Items] | ' | ' |
Expected severance cost | ' | $1.10 |
Severance cost | ' | 0.8 |
Accelerated amortization of prior pension losses | $0.10 | ' |
Restructuring_and_Other_Charge3
Restructuring and Other Charges Activity Related to Restructuring Accruals (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 |
Restructuring Reserve [Roll Forward] | ' | ' | ' | ' |
Beginning Balance | $1,462 | $4,703 | $1,412 | $2,021 |
Expense | 772 | 751 | 1,519 | 5,354 |
Utilization | -682 | -2,890 | -1,379 | -4,811 |
Ending Balance | 1,552 | 2,564 | 1,552 | 2,564 |
Facilities and Other | ' | ' | ' | ' |
Restructuring Reserve [Roll Forward] | ' | ' | ' | ' |
Beginning Balance | 57 | 265 | 155 | 0 |
Expense | 7 | 112 | 13 | 690 |
Utilization | -64 | -144 | -168 | -457 |
Ending Balance | 0 | 233 | 0 | 233 |
Workforce-related | ' | ' | ' | ' |
Restructuring Reserve [Roll Forward] | ' | ' | ' | ' |
Beginning Balance | 1,405 | 4,438 | 1,257 | 2,021 |
Expense | 765 | 639 | 1,506 | 4,664 |
Utilization | -618 | -2,746 | -1,211 | -4,354 |
Ending Balance | $1,552 | $2,331 | $1,552 | $2,331 |
Employee_Benefit_Plans_Narrati
Employee Benefit Plans Narrative (Detail) (USD $) | 6 Months Ended | 3 Months Ended |
In Millions, unless otherwise specified | Mar. 31, 2013 | Dec. 31, 2012 |
Nexus Plan | ||
Defined Benefit Plan Disclosure [Line Items] | ' | ' |
Accelerated amortization of prior pension losses | $0.10 | $0.10 |
Employee_Benefit_Plans_Compone
Employee Benefit Plans Components of Net Pension Cost (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 |
Compensation and Retirement Disclosure [Abstract] | ' | ' | ' | ' |
Service cost | $102 | $144 | $202 | $322 |
Interest cost | 39 | 35 | 78 | 80 |
Amortization of losses | 0 | 1 | 1 | 3 |
Expected return on assets | -55 | -58 | -108 | -135 |
Net periodic pension cost | 86 | 122 | 173 | 270 |
Settlement loss | 0 | 0 | 0 | 87 |
Total pension cost | $86 | $122 | $173 | $357 |
Capital_Lease_Obligation_Narra
Capital Lease Obligation - Narrative (Details) (USD $) | Mar. 31, 2014 |
In Millions, unless otherwise specified | |
Building | ' |
Operating Leased Assets [Line Items] | ' |
Capital lease costs included in balance sheet as property, plant and equipment | $6.40 |
Land | ' |
Operating Leased Assets [Line Items] | ' |
Capital lease costs included in balance sheet as property, plant and equipment | $2.10 |
Capital_Lease_Obligation_Sched
Capital Lease Obligation - Schedule of Future Minimum Lease Payments (Details) (USD $) | Mar. 31, 2014 | Sep. 30, 2013 |
In Thousands, unless otherwise specified | ||
Leases [Abstract] | ' | ' |
2014 | $441 | ' |
2015 | 881 | ' |
2016 | 881 | ' |
2017 | 881 | ' |
2018 | 6,901 | ' |
Total minimum lease payments | 9,985 | ' |
Less amounts representing interest | 1,448 | ' |
Total capital lease obligation | 8,537 | ' |
Less current portion of capital lease obligation | 881 | 0 |
Long-term capital lease obligation | $7,656 | $0 |
Other_Balance_Sheet_Informatio2
Other Balance Sheet Information Summary of Account Receivable (Detail) (USD $) | Mar. 31, 2014 | Sep. 30, 2013 |
In Thousands, unless otherwise specified | ||
Valuation and Qualifying Accounts Disclosure [Line Items] | ' | ' |
Accounts receivable | $84,770 | $78,460 |
Accounts receivable, net | 83,440 | 77,483 |
Allowance for Doubtful Accounts | ' | ' |
Valuation and Qualifying Accounts Disclosure [Line Items] | ' | ' |
Less allowances | -1,184 | -863 |
Allowance for Sales Returns | ' | ' |
Valuation and Qualifying Accounts Disclosure [Line Items] | ' | ' |
Less allowances | ($146) | ($114) |
Other_Balance_Sheet_Informatio3
Other Balance Sheet Information Summary of Inventories (Detail) (USD $) | Mar. 31, 2014 | Sep. 30, 2013 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' | ' |
Raw materials and purchased parts | $59,844,000 | $57,678,000 |
Work-in-process | 17,083,000 | 19,991,000 |
Finished goods | 16,823,000 | 16,742,000 |
Inventory, net | 93,750,000 | 94,411,000 |
Reserves for excess and obsolete inventory | $24,100,000 | ' |
Other_Balance_Sheet_Informatio4
Other Balance Sheet Information Product Warranty and Retrofit Activity on Gross Basis (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' | ' | ' | ' |
Beginning Balance | $6,762 | $7,637 | $7,260 | $7,246 |
Adjustments for acquisitions and divestitures | 0 | 0 | 0 | 962 |
Accruals | 2,275 | 2,985 | 4,150 | 5,317 |
Costs incurred | -2,718 | -2,987 | -5,091 | -5,890 |
Ending Balance | $6,319 | $7,635 | $6,319 | $7,635 |
Equity_Method_Investments_Narr
Equity Method Investments Narrative (Detail) (USD $) | 3 Months Ended | 6 Months Ended | |||
Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 | Sep. 30, 2013 | |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ' |
Equity in earnings (losses) of joint ventures | $510,000 | ($10,000) | $1,259,000 | ($16,000) | ' |
Equity investment in joint ventures | 30,342,000 | ' | 30,342,000 | ' | 25,687,000 |
BioCision, LLC | ' | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ' |
Joint venture interest, percentage | 22.00% | ' | 22.00% | ' | ' |
Investment cost | 4,000,000 | ' | 4,000,000 | ' | ' |
ULVAC Cryogenics, Inc. | ' | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ' |
Joint venture interest, percentage | 50.00% | ' | 50.00% | ' | ' |
Equity in earnings (losses) of joint ventures | 500,000 | 0 | 1,200,000 | 100,000 | ' |
Equity investment in joint ventures | 23,400,000 | ' | 23,400,000 | ' | ' |
Management fee payments received | 100,000 | ' | 300,000 | 200,000 | ' |
Charges incurred from related parties | 0 | 100,000 | 100,000 | 400,000 | ' |
Accounts payable for unpaid products and services | 27,000 | ' | 27,000 | ' | 0 |
Yaskawa Brooks Automation, Inc. | ' | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ' |
Joint venture interest, percentage | 50.00% | ' | 50.00% | ' | ' |
Equity in earnings (losses) of joint ventures | 35,000 | 6,000 | 17,000 | -78,000 | ' |
Equity investment in joint ventures | 2,900,000 | ' | 2,900,000 | ' | ' |
Charges incurred from related parties | 200,000 | 200,000 | 300,000 | 300,000 | ' |
Accounts payable for unpaid products and services | 0 | ' | 0 | ' | 47,000 |
Revenues earned from joint ventures | 2,100,000 | 1,300,000 | 2,800,000 | 2,900,000 | ' |
Due from joint venture | $2,100,000 | ' | $2,100,000 | ' | $2,300,000 |
Derivative_Instruments_Realize
Derivative Instruments - Realized Gains (Losses) on Derivative Instruments (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ' | ' | ' | ' |
Realized gains (losses) on derivative instruments not designated as hedging instruments | $0 | $0 | $0 | $0 |
Derivative_Instruments_Notiona
Derivative Instruments - Notional Amounts Outstanding under Foreign Currency Contracts (Detail) (Foreign Exchange Contract, USD $) | Mar. 31, 2014 | Sep. 30, 2013 |
In Thousands, unless otherwise specified | ||
Designated as Hedging Instrument | Buy Currency, U.S. Dollar; Sell Currency, Japanese Yen | ' | ' |
Derivative [Line Items] | ' | ' |
Fair Value of Assets | $91 | ' |
Fair Value of Liabilities | 0 | ' |
Designated as Hedging Instrument | Long | Buy Currency, U.S. Dollar; Sell Currency, Japanese Yen | ' | ' |
Derivative [Line Items] | ' | ' |
Notional Amount | 2,037 | ' |
Designated as Hedging Instrument | Short | Buy Currency, U.S. Dollar; Sell Currency, Japanese Yen | ' | ' |
Derivative [Line Items] | ' | ' |
Notional Amount | 1,946 | ' |
Not Designated as Hedging Instrument | ' | ' |
Derivative [Line Items] | ' | ' |
Fair Value of Assets | 7 | 8 |
Fair Value of Liabilities | -21 | -5 |
Not Designated as Hedging Instrument | Buy Currency, U.S. Dollar; Sell Currency, Japanese Yen | ' | ' |
Derivative [Line Items] | ' | ' |
Fair Value of Assets | 3 | 8 |
Fair Value of Liabilities | 0 | 0 |
Not Designated as Hedging Instrument | Buy Currency, British Pound; Sell Currency, Euro | ' | ' |
Derivative [Line Items] | ' | ' |
Fair Value of Assets | 0 | ' |
Fair Value of Liabilities | -18 | ' |
Not Designated as Hedging Instrument | Buy Currency, U.S. Dollar; Sell Currency, Taiwan Dollar | ' | ' |
Derivative [Line Items] | ' | ' |
Fair Value of Assets | 1 | ' |
Fair Value of Liabilities | 0 | ' |
Not Designated as Hedging Instrument | Buy Currency, Korean Won; Sell Currency, US Dollar | ' | ' |
Derivative [Line Items] | ' | ' |
Fair Value of Assets | 3 | 0 |
Fair Value of Liabilities | 0 | -2 |
Not Designated as Hedging Instrument | Buy Currency, U.S. Dollar; Sell Currency, Israeli Shekel | ' | ' |
Derivative [Line Items] | ' | ' |
Fair Value of Assets | 0 | 0 |
Fair Value of Liabilities | -3 | -3 |
Not Designated as Hedging Instrument | Buy Currency, U.S. Dollar; Sell Currency, Singapore Dollar | ' | ' |
Derivative [Line Items] | ' | ' |
Fair Value of Assets | ' | 0 |
Fair Value of Liabilities | ' | 0 |
Not Designated as Hedging Instrument | Long | ' | ' |
Derivative [Line Items] | ' | ' |
Notional Amount | 7,177 | 3,988 |
Not Designated as Hedging Instrument | Long | Buy Currency, U.S. Dollar; Sell Currency, Japanese Yen | ' | ' |
Derivative [Line Items] | ' | ' |
Notional Amount | 2,976 | 2,770 |
Not Designated as Hedging Instrument | Long | Buy Currency, British Pound; Sell Currency, Euro | ' | ' |
Derivative [Line Items] | ' | ' |
Notional Amount | 2,470 | ' |
Not Designated as Hedging Instrument | Long | Buy Currency, U.S. Dollar; Sell Currency, Taiwan Dollar | ' | ' |
Derivative [Line Items] | ' | ' |
Notional Amount | 698 | ' |
Not Designated as Hedging Instrument | Long | Buy Currency, Korean Won; Sell Currency, US Dollar | ' | ' |
Derivative [Line Items] | ' | ' |
Notional Amount | 605 | 686 |
Not Designated as Hedging Instrument | Long | Buy Currency, U.S. Dollar; Sell Currency, Israeli Shekel | ' | ' |
Derivative [Line Items] | ' | ' |
Notional Amount | 428 | 301 |
Not Designated as Hedging Instrument | Long | Buy Currency, U.S. Dollar; Sell Currency, Singapore Dollar | ' | ' |
Derivative [Line Items] | ' | ' |
Notional Amount | ' | 231 |
Not Designated as Hedging Instrument | Short | ' | ' |
Derivative [Line Items] | ' | ' |
Notional Amount | 7,191 | 3,985 |
Not Designated as Hedging Instrument | Short | Buy Currency, U.S. Dollar; Sell Currency, Japanese Yen | ' | ' |
Derivative [Line Items] | ' | ' |
Notional Amount | 2,973 | 2,762 |
Not Designated as Hedging Instrument | Short | Buy Currency, British Pound; Sell Currency, Euro | ' | ' |
Derivative [Line Items] | ' | ' |
Notional Amount | 2,488 | ' |
Not Designated as Hedging Instrument | Short | Buy Currency, U.S. Dollar; Sell Currency, Taiwan Dollar | ' | ' |
Derivative [Line Items] | ' | ' |
Notional Amount | 697 | ' |
Not Designated as Hedging Instrument | Short | Buy Currency, Korean Won; Sell Currency, US Dollar | ' | ' |
Derivative [Line Items] | ' | ' |
Notional Amount | 602 | 688 |
Not Designated as Hedging Instrument | Short | Buy Currency, U.S. Dollar; Sell Currency, Israeli Shekel | ' | ' |
Derivative [Line Items] | ' | ' |
Notional Amount | 431 | 304 |
Not Designated as Hedging Instrument | Short | Buy Currency, U.S. Dollar; Sell Currency, Singapore Dollar | ' | ' |
Derivative [Line Items] | ' | ' |
Notional Amount | ' | $231 |
Marketable_Securities_Summary_
Marketable Securities Summary of Marketable Securities Including Accrued Interest Receivable (Detail) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2014 | Sep. 30, 2013 |
Schedule of Available-for-sale Securities [Line Items] | ' | ' |
Amortized Cost | $106,934 | $90,404 |
Gross Unrealized Gains | 82 | 57 |
Gross Unrealized Losses | -74 | -70 |
Fair Value | 106,942 | 90,391 |
U.S. Treasury securities and obligations of U.S. government agencies | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' |
Amortized Cost | 15,876 | 19,528 |
Gross Unrealized Gains | 3 | 6 |
Gross Unrealized Losses | -35 | -13 |
Fair Value | 15,844 | 19,521 |
Corporate securities | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' |
Amortized Cost | 53,419 | 35,045 |
Gross Unrealized Gains | 36 | 11 |
Gross Unrealized Losses | -30 | -47 |
Fair Value | 53,425 | 35,009 |
Mortgage-backed securities | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' |
Amortized Cost | 1,035 | 1,093 |
Gross Unrealized Gains | 31 | 25 |
Gross Unrealized Losses | 0 | -1 |
Fair Value | 1,066 | 1,117 |
Other debt securities | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' |
Amortized Cost | 899 | 88 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | 0 | 0 |
Fair Value | 899 | 88 |
Municipal securities | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' |
Amortized Cost | 23,882 | 25,199 |
Gross Unrealized Gains | 11 | 15 |
Gross Unrealized Losses | -9 | -7 |
Fair Value | 23,884 | 25,207 |
Bank certificate of deposits | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' |
Amortized Cost | 11,823 | 9,451 |
Gross Unrealized Gains | 1 | 0 |
Gross Unrealized Losses | 0 | -2 |
Fair Value | $11,824 | $9,449 |
Marketable_Securities_Fair_Val
Marketable Securities Fair Value of Marketable Securities by Contractual Maturity (Detail) (USD $) | Mar. 31, 2014 | Sep. 30, 2013 |
In Thousands, unless otherwise specified | ||
Investments, Debt and Equity Securities [Abstract] | ' | ' |
Due in one year or less | $50,274 | ' |
Due after one year through five years | 53,291 | ' |
Due after ten years | 3,377 | ' |
Fair Value | $106,942 | $90,391 |
Fair_Value_Measurements_Narrat
Fair Value Measurements Narrative (Detail) (USD $) | Mar. 31, 2014 | Sep. 30, 2013 |
In Thousands, unless otherwise specified | ||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ' | ' |
Available-for-sale securities | $106,942 | $90,391 |
Fair Value, Measurements, Recurring | ' | ' |
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ' | ' |
Available-for-sale securities | 106,942 | 90,391 |
Cash and Cash Equivalents, Fair Value Disclosure | 6,532 | 7,754 |
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | ' | ' |
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ' | ' |
Available-for-sale securities | 0 | 2,199 |
Cash and Cash Equivalents, Fair Value Disclosure | 16 | 6,152 |
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | ' | ' |
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ' | ' |
Available-for-sale securities | 106,942 | 88,192 |
Cash and Cash Equivalents, Fair Value Disclosure | $6,516 | $1,602 |
Fair_Value_Measurements_Assets
Fair Value Measurements Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) (USD $) | Mar. 31, 2014 | Sep. 30, 2013 |
In Thousands, unless otherwise specified | ||
Assets | ' | ' |
Available-for-sale securities | $106,942 | $90,391 |
Fair Value, Measurements, Recurring | ' | ' |
Assets | ' | ' |
Cash Equivalents | 6,532 | 7,754 |
Available-for-sale securities | 106,942 | 90,391 |
Foreign exchange contracts | 98 | 31 |
Total Assets | 113,572 | 98,176 |
Liabilities | ' | ' |
Foreign exchange contracts | ' | 5 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value, Measurements, Recurring | ' | ' |
Assets | ' | ' |
Cash Equivalents | 16 | 6,152 |
Available-for-sale securities | 0 | 2,199 |
Foreign exchange contracts | 0 | 0 |
Total Assets | 16 | 8,351 |
Liabilities | ' | ' |
Foreign exchange contracts | 0 | 0 |
Significant Other Observable Inputs (Level 2) | Fair Value, Measurements, Recurring | ' | ' |
Assets | ' | ' |
Cash Equivalents | 6,516 | 1,602 |
Available-for-sale securities | 106,942 | 88,192 |
Foreign exchange contracts | 98 | 31 |
Total Assets | 113,556 | 89,825 |
Liabilities | ' | ' |
Foreign exchange contracts | $21 | $5 |
Commitments_and_Contingencies_
Commitments and Contingencies - Additional Information (Details) (USD $) | Mar. 31, 2014 |
In Millions, unless otherwise specified | |
Commitments and Contingencies Disclosure [Abstract] | ' |
Outstanding letters of credit | $20.50 |
Subsequent_Events_Detail
Subsequent Events (Detail) (USD $) | 3 Months Ended | 6 Months Ended | 0 Months Ended | |||
In Millions, except Per Share data, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 | 8-May-14 | Apr. 30, 2014 |
Subsequent Event | Subsequent Event | |||||
Subsequent Event [Line Items] | ' | ' | ' | ' | ' | ' |
Purchase price | ' | ' | ' | ' | ' | $31 |
Liabilities incurred | ' | ' | ' | ' | ' | $16 |
Cash dividend declared (USD per share) | $0.08 | $0.08 | $0.16 | $0.16 | $0.08 | ' |
Cash dividend declared, payment date | ' | ' | ' | ' | 27-Jun-14 | ' |
Cash dividend declared, record date | ' | ' | ' | ' | 6-Jun-14 | ' |